##### Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q

CHECK ONE

|  |  |                                                                                         
|- |  | ----------------------------------------------------------------------------------------
|x |  | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 
|  |  |                                                                                         
|  |  | For the Quarterly Period Ended: June 30, 2003                                           
|  |  |                                                                                         
|  |  | OR                                                                                      
|  |  |                                                                                         
|o |  | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
|  |  |                                                                                         
|  |  | For the transition period from ____________ to ____________                             

American HomePatient, Inc.




(Debtor-in-Possession as of July 31, 2002)
(exact name of registrant as specified in its charter)


|                                                               |  |                          |  |                                  
|-------------------------------------------------------------- |  | ------------------------ |  | ---------------------------------
|Delaware                                                       |  | 0-19532                  |  | 62-1474680                       
|                                                               |  |                          |  |                                  
|(State or other jurisdiction of
incorporation or organization) |  | (Commission
File Number) |  | (IRS Employer
Identification No.)

5200 Maryland Way, Suite 400, Brentwood, Tennessee 37027




(Address of principal executive offices) (Zip Code)


(615) 221-8884




(Registrants telephone number, including area code)


None




(Former name, former address and former fiscal year, if changes since last report)


Indicate by check mark whether the registrant: (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.   Yes x   No o

Indicate by check mark whether the registrant is an accelerated filer (as
defined in Exchange Act Rule 12b-2).   Yes o   No x

16,367,389




(Outstanding shares of the issuers common stock as of August 5, 2003)


Total number of sequentially
numbered pages is 58





---

TABLE OF CONTENTS



|                                                             |  |  |  |  |  |  |  | 
|------------------------------------------------------------ |  |  |  |  |  |  |  | 
|PART I. FINANCIAL INFORMATION                               
|INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS               
|INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS     
|INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS     
|NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
|Condensed Combining Balance Sheets as of June 30, 2003      
|Condensed Combining Statements of Operations                
|Condensed Combining Statements of Cash Flows                
|PART II. OTHER INFORMATION                                  
|SIGNATURES                                                  
|INDEX TO EXHIBITS                                           
|EX-31.1  SECTION 302 CERTIFICATION OF THE CEO               
|EX-31.2  SECTION 302 CERTIFICATION OF THE CFO               
|EX-32.1  SECTION 906 CERTIFICATION OF THE CEO               
|EX-32.2  SECTION 906 CERTIFICATION OF THE CFO               



---



##### Table of Contents






PART I. FINANCIAL INFORMATION

ITEM 1  FINANCIAL STATEMENTS

AMERICAN HOMEPATIENT, INC. AND SUBSIDIARIES
(DEBTOR-IN-POSSESSION)




INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS


(unaudited)


ASSETS

|                                 |                                                                                                        |              |                             |              |             |             |              |              |             |             | 
|-------------------------------- | ------------------------------------------------------------------------------------------------------ | ------------ | --------------------------- | ------------ | ----------- | ----------- | ------------ | ------------ | ----------- | ----------- | 
|                                 |                                                                                                        |              |                             |              | June 30,    |             | December 31,
|                                 |                                                                                                        |              |                             |              | 2003        |             | 2002        
|                                 |                                                                                                        |              |                             |              |             |             |             
|CURRENT ASSETS:                  |                                                                                                        |              |                             |              |             |             |              |             
|                                 | Cash and cash equivalents                                                                              |              | $                           | 21,531,000   |             |             | $            | 22,827,000   |            
|                                 | Restricted cash                                                                                        |              |                             | 467,000      |             |             |              | 67,000       |            
|                                 | Accounts receivable, less allowance for
doubtful accounts of $19,685,000 and
$22,991,000, respectively |              |                             | 55,984,000   |             |             |              | 55,437,000   |            
|                                 | Inventories, net of inventory reserves of
$562,000 and $583,000, respectively                          |              |                             | 15,048,000   |             |             |              | 16,565,000   |            
|                                 | Prepaid expenses and other current assets                                                              |              |                             | 2,695,000    |             |             |              | 2,276,000    |            
|                                 |                                                                                                        |              |                             |              |             |             |              |              |            
|                                 |                                                                                                        |              | Total current assets        |              |             | 95,725,000  |              |              |             | 97,172,000  | 
|                                 |                                                                                                        |              |                             |              |             |             |              |              |            
|PROPERTY AND EQUIPMENT, at cost: |                                                                                                        |              | 170,280,000                 |              |             |             | 171,021,000  |             
|                                 | Less accumulated depreciation and amortization                                                         |              |                             | (117,664,000 | )           |             |              | (120,594,000 | )          
|                                 |                                                                                                        |              |                             |              |             |             |              |              |            
|                                 |                                                                                                        |              | Property and equipment, net |              |             | 52,616,000  |              |              |             | 50,427,000  | 
|                                 |                                                                                                        |              |                             |              |             |             |              |              |            
|OTHER ASSETS:                    |                                                                                                        |              |                             |              |             |             |              |             
|                                 | Goodwill, net                                                                                          |              |                             | 121,214,000  |             |             |              | 121,214,000  |            
|                                 | Investment in joint ventures                                                                           |              |                             | 8,950,000    |             |             |              | 9,815,000    |            
|                                 | Other assets                                                                                           |              |                             | 12,661,000   |             |             |              | 12,315,000   |            
|                                 |                                                                                                        |              |                             |              |             |             |              |              |            
|                                 |                                                                                                        |              | Total other assets          |              |             | 142,825,000 |              |              |             | 143,344,000 | 
|                                 |                                                                                                        |              |                             |              |             |             |              |              |            
|                                 |                                                                                                        | TOTAL ASSETS |                             | $            | 291,166,000 |             |              | $            | 290,943,000 |            
|                                 |                                                                                                        |              |                             |              |             |             |              |              |            

(Continued)

2



---



##### Table of Contents



AMERICAN HOMEPATIENT, INC. AND SUBSIDIARIES
(DEBTOR-IN-POSSESSION)
INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS
(unaudited)
(Continued)

LIABILITIES AND SHAREHOLDERS DEFICIT

|                                       |                                                                                                       |                                              |                                             |                              |           |             |             |              |           |             |             |  
|-------------------------------------- | ----------------------------------------------------------------------------------------------------- | -------------------------------------------- | ------------------------------------------- | ---------------------------- | --------- | ----------- | ----------- | ------------ | --------- | ----------- | ----------- | -
|                                       |                                                                                                       |                                              |                                             |                              |           | June 30,    |             | December 31,
|                                       |                                                                                                       |                                              |                                             |                              |           | 2003        |             | 2002        
|                                       |                                                                                                       |                                              |                                             |                              |           |             |             |             
|LIABILITIES NOT SUBJECT TO COMPROMISE: |                                                                                                       |                                              |                                             |                              |           |             |             |             
|CURRENT LIABILITIES:                   |                                                                                                       |                                              |                                             |                              |           |             |             |             
|                                       | Accounts payable                                                                                      |                                              | $                                           | 13,701,000                   |           |             | $           | 13,267,000   |          
|                                       | Other payables                                                                                        |                                              |                                             | 1,897,000                    |           |             |             | 1,637,000    |          
|                                       | Accrued expenses:                                                                                     |                                              |                                             |                              |           |             |             |              |          
|                                       |                                                                                                       | Payroll and related benefits                 |                                             |                              | 6,792,000 |             |             |              | 7,759,000 |            
|                                       |                                                                                                       | Insurance, including self-insurance reserves |                                             |                              | 6,507,000 |             |             |              | 5,829,000 |            
|                                       |                                                                                                       | Other                                        |                                             |                              | 1,617,000 |             |             |              | 1,625,000 |            
|                                       |                                                                                                       |                                              |                                             |                              |           |             |             |              |          
|                                       |                                                                                                       |                                              |                                             | Total current liabilities    |           |             | 30,514,000  |              |           |             | 30,117,000  |  
|                                       |                                                                                                       |                                              |                                             |                              |           |             |             |              |          
|NONCURRENT LIABILITIES:                |                                                                                                       |                                              |                                             |                              |           |             |             |             
|                                       | Minority interest                                                                                     |                                              |                                             | 486,000                      |           |             |             | 470,000      |          
|                                       | Other noncurrent liabilities                                                                          |                                              |                                             | 106,000                      |           |             |             | 121,000      |          
|                                       |                                                                                                       |                                              |                                             |                              |           |             |             |              |          
|                                       |                                                                                                       |                                              |                                             | Total noncurrent liabilities |           |             | 592,000     |              |           |             | 591,000     |  
|                                       |                                                                                                       |                                              |                                             |                              |           |             |             |              |          
|LIABILITIES SUBJECT TO COMPROMISE      |                                                                                                       |                                              | 298,797,000                                 |                              |           |             | 307,829,000 |             
|                                      
|SHAREHOLDERS DEFICIT                  |                                                                                                       |                                              |                                             |                              |           |             |             |             
|                                       | Preferred stock, $.01 par value; authorized 5,000,000
shares; none issued and outstanding             |                                              |                                             |                             |           |             |             |             |          
|                                       | Common stock, $.01 par value; authorized 35,000,000
shares; issued and outstanding, 16,367,000 shares |                                              |                                             | 164,000                      |           |             |             | 164,000      |          
|                                       | Paid-in capital                                                                                       |                                              |                                             | 173,985,000                  |           |             |             | 173,985,000  |          
|                                       | Accumulated deficit                                                                                   |                                              |                                             | (212,886,000                 | )         |             |             | (221,743,000 | )        
|                                       |                                                                                                       |                                              |                                             |                              |           |             |             |              |          
|                                       |                                                                                                       |                                              |                                             | Total shareholders deficit  |           |             | (38,737,000 | )            |           |             | (47,594,000 | )
|                                       |                                                                                                       |                                              |                                             |                              |           |             |             |              |          
|                                       |                                                                                                       |                                              | TOTAL LIABILITIES AND SHAREHOLDERS DEFICIT |                              | $         | 291,166,000 |             |              | $         | 290,943,000 |            
|                                       |                                                                                                       |                                              |                                             |                              |           |             |             |              |          

(Concluded)

The accompanying notes to interim condensed consolidated financial statements
are an integral part of these consolidated financial statements.

3



---



##### Table of Contents



AMERICAN HOMEPATIENT, INC. AND SUBSIDIARIES
(DEBTOR-IN-POSSESSION)




INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS


(unaudited)


|                                                                                                                                |                                                                                                                                                |           |                |            |                             |            |                           |            |            |            |            |            |            |             |             |            |            |             | 
|------------------------------------------------------------------------------------------------------------------------------- | ---------------------------------------------------------------------------------------------------------------------------------------------- | --------- | -------------- | ---------- | --------------------------- | ---------- | ------------------------- | ---------- | ---------- | ---------- | ---------- | ---------- | ---------- | ----------- | ----------- | ---------- | ---------- | ----------- | 
|                                                                                                                                |                                                                                                                                                |           |                |            | Three Months Ended June 30, |            | Six Months Ended June 30,
|                                                                                                                                |                                                                                                                                                |           |                |            |                             |            |                          
|                                                                                                                                |                                                                                                                                                |           |                |            | 2003                        |            | 2002                      |            | 2003       |            | 2002      
|                                                                                                                                |                                                                                                                                                |           |                |            |                             |            |                           |            |            |            |           
|REVENUES:                                                                                                                       |                                                                                                                                                |           |                |            |                             |            |                           |            |            |            |            |            |            |             |             |           
|                                                                                                                                | Sales and related service revenues                                                                                                             |           | $              | 36,199,000 |                             |            | $                         | 33,757,000 |            |            | $          | 72,600,000 |            |             | $           | 68,580,000 |           
|                                                                                                                                | Rentals and other revenues                                                                                                                     |           |                | 46,665,000 |                             |            |                           | 45,322,000 |            |            |            | 92,771,000 |            |             |             | 90,311,000 |           
|                                                                                                                                |                                                                                                                                                |           |                |            |                             |            |                           |            |            |            |            |            |            |             |             |            |           
|                                                                                                                                |                                                                                                                                                |           | Total revenues |            |                             | 82,864,000 |                           |            |            | 79,079,000 |            |            |            | 165,371,000 |             |            |            | 158,891,000 | 
|                                                                                                                                |                                                                                                                                                |           |                |            |                             |            |                           |            |            |            |            |            |            |             |             |            |           
|EXPENSES:                                                                                                                       |                                                                                                                                                |           |                |            |                             |            |                           |            |            |            |            |            |            |             |             |           
|                                                                                                                                | Cost of sales and related services                                                                                                             |           |                | 17,449,000 |                             |            |                           | 15,561,000 |            |            |            | 34,742,000 |            |             |             | 32,065,000 |           
|                                                                                                                                | Cost of rentals and other revenues, including rental
equipment depreciation of $5,088,000, $4,767,000,
$9,829,000 and $9,406,000, respectively |           |                | 8,970,000  |                             |            |                           | 8,580,000  |            |            |            | 17,396,000 |            |             |             | 16,766,000 |           
|                                                                                                                                | Operating, including bad debt expense of $2,206,000,
$2,699,000, $5,323,000 and $6,869,000, respectively                                       |           |                | 46,018,000 |                             |            |                           | 44,853,000 |            |            |            | 93,254,000 |            |             |             | 91,189,000 |           
|                                                                                                                                | General and administrative                                                                                                                     |           |                | 4,126,000  |                             |            |                           | 4,055,000  |            |            |            | 8,672,000  |            |             |             | 8,317,000  |           
|                                                                                                                                | Earnings from joint ventures                                                                                                                   |           |                | (1,191,000 | )                           |            |                           | (1,119,000 | )          |            |            | (2,421,000 | )          |             |             | (2,392,000 | )         
|                                                                                                                                | Depreciation, excluding rental equipment, and amortization                                                                                     |           |                | 846,000    |                             |            |                           | 1,069,000  |            |            |            | 1,771,000  |            |             |             | 2,102,000  |           
|                                                                                                                                | Amortization of deferred financing costs                                                                                                       |           |                |           |                             |            |                           | 719,000    |            |            |            |           |            |             |             | 1,543,000  |           
|                                                                                                                                | Interest expense (income), net (excluding post-petition
contractual interest
of $6,210,000, $0, $12,510,000 and $0, respectively)              |           |                | 22,000     |                             |            |                           | 5,076,000  |            |            |            | (50,000    | )          |             |             | 10,191,000 |           
|                                                                                                                                | Other (income) expense, net                                                                                                                    |           |                |           |                             |            |                           | (65,000    | )          |            |            | 94,000     |            |             |             | (169,000   | )         
|                                                                                                                                | Gain on sale of assets of center                                                                                                               |           |                |           |                             |            |                           |           |            |            |            |           |            |             |             | (667,000   | )         
|                                                                                                                                | Chapter 11 financial advisory expenses incurred prior to
filing bankruptcy                                                                     |           |                |           |                             |            |                           | 314,000    |            |            |            |           |            |             |             | 314,000    |           
|                                                                                                                                |                                                                                                                                                |           |                |            |                             |            |                           |            |            |            |            |            |            |             |             |            |           
|                                                                                                                                |                                                                                                                                                |           | Total expenses |            |                             | 76,240,000 |                           |            |            | 79,043,000 |            |            |            | 153,458,000 |             |            |            | 159,259,000 | 
|                                                                                                                                |                                                                                                                                                |           |                |            |                             |            |                           |            |            |            |            |            |            |             |             |            |           
|INCOME (LOSS) FROM OPERATIONS BEFORE REORGANIZATION ITEMS,
INCOME TAXES AND CUMULATIVE EFFECT OF CHANGE IN ACCOUNTING
PRINCIPLE |                                                                                                                                                |           | 6,624,000      |            |                             |            | 36,000                    |            |            |            | 11,913,000 |            |            |             | (368,000    | )         
|REORGANIZATION ITEMS                                                                                                            |                                                                                                                                                |           | 2,004,000      |            |                             |            |                          |            |            |            | 2,856,000  |            |            |             |            |           
|                                                                                                                                |                                                                                                                                                |           |                |            |                             |            |                           |            |            |            |            |            |            |             |             |            |           
|INCOME (LOSS) FROM OPERATIONS BEFORE INCOME TAXES AND
CUMULATIVE EFFECT OF CHANGE IN ACCOUNTING PRINCIPLE                       |                                                                                                                                                |           | 4,620,000      |            |                             |            | 36,000                    |            |            |            | 9,057,000  |            |            |             | (368,000    | )         
|PROVISION FOR (BENEFIT FROM) INCOME TAXES                                                                                       |                                                                                                                                                |           | 100,000        |            |                             |            | 100,000                   |            |            |            | 200,000    |            |            |             | (1,912,000  | )         
|                                                                                                                                |                                                                                                                                                |           |                |            |                             |            |                           |            |            |            |            |            |            |             |             |            |           
|INCOME (LOSS) BEFORE CUMULATIVE EFFECT OF CHANGE IN
ACCOUNTING PRINCIPLE                                                        |                                                                                                                                                |           | 4,520,000      |            |                             |            | (64,000                   | )          |            |            | 8,857,000  |            |            |             | 1,544,000   |           
|                                                                                                                               
|CUMULATIVE EFFECT OF CHANGE IN ACCOUNTING PRINCIPLE WITH NO
RELATED TAX EFFECT                                                  |                                                                                                                                                |           |               |            |                             |            |                          |            |            |            |           |            |            |             | (68,485,000 | )         
|                                                                                                                                |                                                                                                                                                |           |                |            |                             |            |                           |            |            |            |            |            |            |             |             |            |           
|NET INCOME (LOSS)                                                                                                               |                                                                                                                                                | $         | 4,520,000      |            |                             | $          | (64,000                   | )          |            | $          | 8,857,000  |            |            | $           | (66,941,000 | )         
|                                                                                                                                |                                                                                                                                                |           |                |            |                             |            |                           |            |            |            |            |            |            |             |             |            |           
|INCOME (LOSS) PER COMMON SHARE BEFORE CUMULATIVE EFFECT OF                                                                      |                                                                                                                                                |           |                |            |                             |            |                           |            |            |            |            |            |            |             |             |           
|                                                                                                                                | CHANGE IN ACCOUNTING PRINCIPLE:                                                                                                                |           |                |            |                             |            |                           |            |            |            |            |            |            |             |             |            |           
|                                                                                                                                |                                                                                                                                                |  Basic   |                | $          | 0.28                        |            |                           | $          |           |            |            | $          | 0.54       |             |             | $          | 0.09       |            
|                                                                                                                                |                                                                                                                                                |           |                |            |                             |            |                           |            |            |            |            |            |            |             |             |            |           
|                                                                                                                                |                                                                                                                                                |  Diluted |                | $          | 0.24                        |            |                           | $          |           |            |            | $          | 0.47       |             |             | $          | 0.08       |            
|                                                                                                                                |                                                                                                                                                |           |                |            |                             |            |                           |            |            |            |            |            |            |             |             |            |           
|CUMULATIVE EFFECT OF CHANGE IN ACCOUNTING
PRINCIPLE PER COMMON SHARE:                                                           |                                                                                                                                                |           |                |            |                             |            |                           |            |            |            |            |            |            |             |             |           
|                                                                                                                                |                                                                                                                                                |  Basic   |                | $          |                            |            |                           | $          |           |            |            | $          |           |             |             | $          | (4.19      | )          
|                                                                                                                                |                                                                                                                                                |           |                |            |                             |            |                           |            |            |            |            |            |            |             |             |            |           
|                                                                                                                                |                                                                                                                                                |  Diluted |                | $          |                            |            |                           | $          |           |            |            | $          |           |             |             | $          | (3.66      | )          
|                                                                                                                                |                                                                                                                                                |           |                |            |                             |            |                           |            |            |            |            |            |            |             |             |            |           
|NET INCOME (LOSS) PER COMMON SHARE:                                                                                             |                                                                                                                                                |           |                |            |                             |            |                           |            |            |            |            |            |            |             |             |           
|                                                                                                                                |                                                                                                                                                |  Basic   |                | $          | 0.28                        |            |                           | $          |           |            |            | $          | 0.54       |             |             | $          | (4.10      | )          
|                                                                                                                                |                                                                                                                                                |           |                |            |                             |            |                           |            |            |            |            |            |            |             |             |            |           
|                                                                                                                                |                                                                                                                                                |  Diluted |                | $          | 0.24                        |            |                           | $          |           |            |            | $          | 0.47       |             |             | $          | (3.58      | )          
|                                                                                                                                |                                                                                                                                                |           |                |            |                             |            |                           |            |            |            |            |            |            |             |             |            |           
|WEIGHTED AVERAGE COMMON SHARES
OUTSTANDING:                                                                                     |                                                                                                                                                |           |                |            |                             |            |                           |            |            |            |            |            |            |             |             |           
|                                                                                                                                |                                                                                                                                                |  Basic   |                |            | 16,367,000                  |            |                           |            | 16,367,000 |            |            |            | 16,367,000 |             |             |            | 16,349,000 |            
|                                                                                                                                |                                                                                                                                                |           |                |            |                             |            |                           |            |            |            |            |            |            |             |             |            |           
|                                                                                                                                |                                                                                                                                                |  Diluted |                |            | 18,835,000                  |            |                           |            | 16,367,000 |            |            |            | 18,663,000 |             |             |            | 18,688,000 |            
|                                                                                                                                |                                                                                                                                                |           |                |            |                             |            |                           |            |            |            |            |            |            |             |             |            |           

The accompanying notes to interim condensed consolidated financial statements
are an integral part of these consolidated financial statements.

4



---



##### Table of Contents



AMERICAN HOMEPATIENT, INC. AND SUBSIDIARIES
(DEBTOR-IN-POSSESSION)




INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS


(unaudited)


|                                      |                                                                                          |                                                       |                                           |             |                           |            |      |             |            |            | 
|------------------------------------- | ---------------------------------------------------------------------------------------- | ----------------------------------------------------- | ----------------------------------------- | ----------- | ------------------------- | ---------- | ---- | ----------- | ---------- | ---------- | 
|                                      |                                                                                          |                                                       |                                           |             | Six Months Ended June 30,
|                                      |                                                                                          |                                                       |                                           |             |                          
|                                      |                                                                                          |                                                       |                                           |             | 2003                      |            | 2002
|                                      |                                                                                          |                                                       |                                           |             |                           |            |     
|CASH FLOWS FROM OPERATING ACTIVITIES: |                                                                                          |                                                       |                                           |             |                           |            |      |            
|                                      | Net income (loss)                                                                        |                                                       | $                                         | 8,857,000   |                           |            | $    | (66,941,000 | )         
|                                      | Adjustments to reconcile net income (loss) to net cash
provided by operating activities: |                                                       |                                           |             |                           |            |      |             |           
|                                      |                                                                                          | Cumulative effect of change in accounting principle   |                                           |             |                          |            |      |             | 68,485,000 |           
|                                      |                                                                                          | Depreciation and amortization                         |                                           |             | 11,600,000                |            |      |             | 11,508,000 |           
|                                      |                                                                                          | Amortization of deferred financing costs              |                                           |             |                          |            |      |             | 1,543,000  |           
|                                      |                                                                                          | Provision for doubtful accounts                       |                                           |             | (3,306,000                | )          |      |             | (3,268,000 | )         
|                                      |                                                                                          | Provision for inventory                               |                                           |             | (21,000                   | )          |      |             | (117,000   | )         
|                                      |                                                                                          | Equity in earnings of unconsolidated joint ventures   |                                           |             | (1,338,000                | )          |      |             | (1,409,000 | )         
|                                      |                                                                                          | Minority interest                                     |                                           |             | 179,000                   |            |      |             | 147,000    |           
|                                      |                                                                                          | Gain on sale of assets of center                      |                                           |             |                          |            |      |             | (667,000   | )         
|                                      |                                                                                          | Reorganization items                                  |                                           |             | 2,856,000                 |            |      |             |           |           
|                                      |                                                                                          | Reorganization items paid                             |                                           |             | (2,660,000                | )          |      |             |           |           
|                                      | Change in assets and liabilities net of dispositions:                                    |                                                       |                                           |             |                           |            |      |             |           
|                                      |                                                                                          | Accounts receivable                                   |                                           |             | 2,759,000                 |            |      |             | 7,295,000  |           
|                                      |                                                                                          | Inventories                                           |                                           |             | 1,538,000                 |            |      |             | (132,000   | )         
|                                      |                                                                                          | Prepaid expenses and other current assets             |                                           |             | (419,000                  | )          |      |             | (6,000     | )         
|                                      |                                                                                          | Federal income tax receivable                         |                                           |             |                          |            |      |             | (2,112,000 | )         
|                                      |                                                                                          | Accounts payable, other payables and accrued
expenses |                                           |             | (1,071,000                | )          |      |             | (3,594,000 | )         
|                                      |                                                                                          | Other assets and liabilities                          |                                           |             | (93,000                   | )          |      |             | (20,000    | )         
|                                      |                                                                                          | Other noncurrent liabilities                          |                                           |             | (15,000                   | )          |      |             | 124,000    |           
|                                      |                                                                                          |                                                       |                                           |             |                           |            |      |             |           
|                                      |                                                                                          |                                                       | Net cash provided by operating activities |             |                           | 18,866,000 |      |             |            | 10,836,000 | 
|                                      |                                                                                          |                                                       |                                           |             |                           |            |      |             |           
|CASH FLOWS FROM INVESTING ACTIVITIES: |                                                                                          |                                                       |                                           |             |                           |            |      |            
|                                      | Proceeds from sale of assets of center                                                   |                                                       |                                           |            |                           |            |      | 1,805,000   |           
|                                      | Additions to property and equipment, net                                                 |                                                       |                                           | (13,782,000 | )                         |            |      | (13,016,000 | )         
|                                      | Distributions and loan payments from unconsolidated
joint ventures, net                  |                                                       |                                           | 2,203,000   |                           |            |      | 1,610,000   |           
|                                      |                                                                                          |                                                       |                                           |             |                           |            |      |             |           
|                                      |                                                                                          | Net cash used in investing activities                 |                                           | $           | (11,579,000               | )          |      | $           | (9,601,000 | )         
|                                      |                                                                                          |                                                       |                                           |             |                           |            |      |             |           

(Continued)

5



---



##### Table of Contents



AMERICAN HOMEPATIENT, INC. AND SUBSIDIARIES
(DEBTOR-IN-POSSESSION)
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)
(Continued)

|                                               |                                                         |                                       |            |                           |            |      |            |            |            |  
|---------------------------------------------- | ------------------------------------------------------- | ------------------------------------- | ---------- | ------------------------- | ---------- | ---- | ---------- | ---------- | ---------- | -
|                                               |                                                         |                                       |            | Six Months Ended June 30,
|                                               |                                                         |                                       |            |                          
|                                               |                                                         |                                       |            | 2003                      |            | 2002
|                                               |                                                         |                                       |            |                           |            |     
|CASH FLOWS FROM FINANCING ACTIVITIES:          |                                                         |                                       |            |                           |            |      |            |           
|                                               | Principal payments on long-term debt and capital leases |                                       |            | (226,000                  | )          |      |            | (5,980,000 | )         
|                                               | Adequate protection payments                            |                                       |            | (7,794,000                | )          |      |            |           |           
|                                               | Proceeds from exercise of stock options                 |                                       |            |                          |            |      |            | 11,000     |           
|                                               | Deferred financing costs                                |                                       |            |                          |            |      |            | 189,000    |           
|                                               | Distributions to minority interest owners               |                                       |            | (163,000                  | )          |      |            | (119,000   | )         
|                                               | Restricted cash                                         |                                       |            | (400,000                  | )          |      |            | 198,000    |           
|                                               |                                                         |                                       |            |                           |            |      |            |            |           
|                                               |                                                         | Net cash used in financing activities |            |                           | (8,583,000 | )    |            |            | (5,701,000 | )
|                                               |                                                         |                                       |            |                           |            |      |            |            |           
|DECREASE IN CASH AND CASH EQUIVALENTS          |                                                         |                                       | (1,296,000 | )                         |            |      | (4,466,000 | )         
|CASH AND CASH EQUIVALENTS, beginning of period |                                                         |                                       | 22,827,000 |                           |            |      | 9,129,000  |           
|                                               |                                                         |                                       |            |                           |            |      |            |            |           
|CASH AND CASH EQUIVALENTS, end of period       |                                                         | $                                     | 21,531,000 |                           |            | $    | 4,663,000  |           
|                                               |                                                         |                                       |            |                           |            |      |            |            |           
|SUPPLEMENTAL INFORMATION:                      |                                                         |                                       |            |                           |            |      |            |           
|                                               | Cash payments of interest                               |                                       | $          | 49,000                    |            |      | $          | 11,203,000 |           
|                                               |                                                         |                                       |            |                           |            |      |            |            |           
|                                               | Cash payments of income taxes                           |                                       | $          | 105,000                   |            |      | $          | 299,000    |           
|                                               |                                                         |                                       |            |                           |            |      |            |            |           

(Concluded)

The accompanying notes to interim condensed consolidated financial statements
are an integral part of these consolidated financial statements.

6



---



##### Table of Contents



AMERICAN HOMEPATIENT, INC. AND SUBSIDIARIES
(DEBTOR-IN-POSSESSION)




NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS


1. BASIS OF PRESENTATION

American HomePatient, Inc. was incorporated in Delaware in September 1991.
American HomePatient Inc.s principal executive offices are located at 5200
Maryland Way, Suite 400, Brentwood, Tennessee 37027-5018, and its telephone
number at that address is (615) 221-8884. American HomePatient, Inc. and
subsidiaries (the Company) provides home health care services and products
consisting primarily of respiratory therapies, infusion therapies and the
rental and sale of home medical equipment and home health care supplies. For
the six months ended June 30, 2003, these services represented 68%, 13% and 19%
of revenues, respectively. These services and products are paid for primarily
by Medicare, Medicaid and other third-party payors. As of June 30, 2003, the
Company provided these services to patients primarily in the home through 289
centers in 35 states: Alabama, Arizona, Arkansas, Colorado, Connecticut,
Delaware, Florida, Georgia, Illinois, Iowa, Kansas, Kentucky, Maine, Maryland,
Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Jersey, New
Mexico, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, South Carolina,
South Dakota, Tennessee, Texas, Virginia, Washington, West Virginia and
Wisconsin.

The interim condensed consolidated financial statements of the Company for the
six months ended June 30, 2003 and 2002 herein have been prepared by the
Company, without audit, pursuant to the rules and regulations of the Securities
and Exchange Commission. Certain information and footnote disclosures normally
included in financial statements prepared in accordance with accounting
principles generally accepted in the United States of America have been
condensed or omitted pursuant to such rules and regulations. In the opinion of
management of the Company, the accompanying unaudited interim condensed
consolidated financial statements reflect all adjustments (consisting of only
normally recurring accruals) necessary to present fairly the financial position
at June 30, 2003 and the results of operations and the cash flows for the six
months ended June 30, 2003 and 2002.

The results of operations for the six months ended June 30, 2003 and 2002 are
not necessarily indicative of the operating results for the entire respective
years. These unaudited interim condensed consolidated financial statements
should be read in conjunction with the audited financial statements and notes
thereto included in the Companys Annual Report on Form 10-K.

Certain reclassifications have been made to the 2002 consolidated financial
statements to conform to the 2003 presentation.

2. HISTORY OF BANK CREDIT FACILITY

Overview.The Company is indebted to a syndicate of lenders (the
Lenders), with Bank of Montreal serving as agent for the Lenders. The
indebtedness arose out of a credit agreement entitled the Fifth Amended and
Restated Credit Agreement (the Amended Credit Agreement), which Amended
Credit Agreement was entered into as of June 8, 2001. The indebtedness owed to
the Lenders as of July 31, 2002, the date of the Companys Bankruptcy Filing
(as defined in

7



---



##### Table of Contents



Note 3), totaled approximately $278.7 million. Terms, including payment terms,
for the indebtedness that arose out of the Amended Credit Agreement have been
established by the Second Amended Joint Plan of Reorganization approved by the
United States Bankruptcy Court for the Middle District of Tennessee (the
Approved Plan) and are discussed in more detail in Note 14. The terms of the
Amended Credit Agreement have been superseded by the terms of the Second
Amended Joint Plan of Reorganization. See Note 3.

Historical Terms of the Bank Credit Facility.Prior to August 12, 2002,
Deutsche Bank Trust Company, successor to Bankers Trust Company, served as
agent for the Lenders under the Amended Credit Agreement. On August 12, 2002
the Company received written notice that Deutsche Bank Trust Company intended
to resign. Bank of Montreal was appointed by the Lenders as the new agent.

The Amended Credit Agreement was the latest in a series of credit agreements in
connection with a credit facility (the Bank Credit Facility) that dated back
to October 20, 1994. The Amended Credit Agreement was entered into after the
Company breached several of the financial covenants in the Fourth Amended and
Restated Credit Agreement.

The Amended Credit Agreement provided a new loan to the Company from which the
proceeds were used to pay off all existing loans under the Fourth Amended and
Restated Credit Agreement. The Amended Credit Agreement also included modified
financial covenants and a revised amortization schedule. In addition, the
Amended Credit Agreement no longer contained a revolving loan component; all
existing indebtedness was now in the form of a term loan which matured on
December 31, 2002.

Substantially all of the Companys assets were pledged as security for
borrowings under the Bank Credit Facility.

The Amended Credit Agreement required principal payments of $750,000 on
September 30, 2001 and December 31, 2001; a principal payment of $11.6 million
on March 31, 2002; principal payments of $1.0 million on June 30, 2002 and
September 30, 2002; and a balloon payment of $281.5 million on December 31,
2002. The Amended Credit Agreement further provided for mandatory prepayments
of principal from the Companys excess cash flow and from the proceeds of the
Companys sales of securities, sales of assets, tax refunds or excess casualty
loss payments.

As of July 31, 2002, the Company had paid the $750,000 principal payment due on
September 30, 2001, the $750,000 principal payment due on December 31, 2001,
the $11.6 million principal payment due on March 31, 2002 as well as the $1.0
million principal payment due on June 30, 2002, the $1.0 million principal
payment due on September 30, 2002, and $6.1 million of the balloon payment due
on December 31, 2002. These early payments of 2002 principal were generated
from operational cash flows, from the sales of assets of centers, from the
sales of the Companys wholly-owned real estate and from the collection of
patient receivables associated with the asset sales. The Bankruptcy Filing
stayed all remaining payments required by the Amended Credit Agreement.

8



---



##### Table of Contents



The Amended Credit Agreement further provided for the payment to the Lenders of
certain fees. These fees included a restructuring fee of $1.2 million (paid on
the effective date of the Amended Credit Agreement), and $200,000 paid on
December 31, 2001, March 31, 2002 and June 30, 2002. A restructuring fee of
$459,000 payable on September 30, 2002 is currently classified as a liability
subject to compromise in the accompanying consolidated balance sheet as of June
30, 2003. In addition, the Company had an obligation to pay the agent an
annual administrative fee of $75,000 and an annual fee of 0.50% of the average
monthly outstanding indebtedness on each anniversary of the Amended Credit
Agreement. The last such payment of annual fees was made by the Company in
June 2002.

The Amended Credit Agreement contained various financial covenants, the most
restrictive of which related to measurements of EBITDA (as defined in the
Amended Credit Agreement), leverage, interest coverage ratios, and collections
of accounts receivable. The Amended Credit Agreement also contained provisions
for periodic reporting.

The Amended Credit Agreement also contained restrictions which, among other
things, imposed certain limitations or prohibitions on the Company with respect
to the incurrence of indebtedness, the creation of liens, the payment of
dividends, the redemption or repurchase of securities, investments,
acquisitions, capital expenditures, sales of assets and transactions with
affiliates. The Company was not permitted to make acquisitions or investments
in joint ventures without the consent of Lenders holding a majority of the
lending commitments under the Bank Credit Facility. In addition, proceeds of
all of the Companys accounts receivable were transferred daily into a bank
account at PNC Bank, N.A. which, under the terms of a Concentration Bank
Agreement, required that all amounts in excess of $3.0 million be transferred
to an account at Deutsche Bank Trust Company (predecessor agent for the
Lenders) in the Companys name. Upon occurrence of an event of default under
the Amended Credit Agreement, the Lenders had the right to instruct PNC Bank,
N.A. and Deutsche Bank Trust Company to cease honoring any drafts under the
accounts and apply all amounts in the bank accounts against the indebtedness
owed to the Lenders.

Interest was payable on the unpaid principal amount under the Amended Credit
Agreement, at the election of the Company, at either a Base Lending Rate or an
Adjusted Eurodollar Rate (each as defined in the Amended Credit Agreement),
plus an applicable margin of 2.75% and 3.50%, respectively. The Company was
also required to pay additional interest in the amount of 4.50% per annum on
that principal portion outstanding of the Amended Credit Agreement that is in
excess of four times adjusted EBITDA, as defined by the Amended Credit
Agreement. For the seven months ended with the Bankruptcy Filing, the weighted
average borrowing rate was 7.3%. Upon the occurrence and continuation of an
event of default under the Amended Credit Agreement, interest would have been
payable upon demand at a rate that is 2.00% per annum in excess of the interest
rate otherwise payable under the Amended Credit Agreement and the Company no
longer would have had the right to designate the Adjusted Eurodollar Rate plus
the applicable margin as the applicable interest rate.

Warrants.The Company was required to issue warrants to the Lenders
representing 19.999% of the common stock of the Company issued and outstanding
as of March 31, 2001, pursuant to the terms of the Second Amendment to the
Fourth Amended and Restated Credit Agreement (which amendment was entered into
on April 14, 1999). To fulfill these obligations, warrants to purchase
3,265,315 shares of common stock were issued to the Lenders on June 8,
2001. Fifty percent of these warrants are exercisable until May 31, 2011, and
the remaining fifty

9



---



##### Table of Contents



percent are exercisable until September 29, 2011. The
exercise price of the warrants is $0.01 per share. The Company accounted for
the fair value of these warrants during the fourth quarter of 2000 as the
issuance of these warrants was determined to be probable. As such, the Company
increased deferred financing costs by $686,000 to recognize the estimated fair
value of the warrants as of December 31, 2000. See Note 14 for further
information.

3. PROCEEDINGS UNDER CHAPTER 11 OF THE BANKRUPTCY CODE

The Amended Credit Agreement was due to mature on December 31, 2002. Because
of the impending maturity and the Companys inability to reach an agreement
with its Lenders to restructure the Bank Credit Facility, on July 31, 2002
American HomePatient, Inc. and 24 of its subsidiaries (collectively, the
Debtors) filed voluntary petitions for relief to reorganize under Chapter 11
of the U.S. Bankruptcy Code (the Bankruptcy Filing) in the United States
Bankruptcy Court for the Middle District of Tennessee (the Bankruptcy Court).
The Bankruptcy Filing stayed all payments and enforcement actions under the
Amended Credit Agreement.

These cases (the Chapter 11 Cases) were consolidated for the purpose of joint
administration under Case Number 02-08915-GP3-11. On January 2, 2003, the
Debtors filed their Second Amended Joint Plan of Reorganization (the Proposed
Plan), proposed by the Debtors and the Official Committee of Unsecured
Creditors appointed by the Office of the United States Trustee in the Chapter
11 Cases. A Disclosure Statement, the purpose of which is to enable creditors
entitled to vote on the Plan to make an informed decision before exercising
their right to vote, accompanied the Plan and was also filed on January 2,
2003. After certain amendments, a Disclosure Statement filed on February 24,
2003, was approved by the Bankruptcy Court. The hearing before the Bankruptcy
Court on confirmation of the Proposed Plan was held on April 2325 and 28-29,
2003. On May 15, 2003, the Bankruptcy Court entered a memorandum opinion
overruling the Lenders objections to the Proposed Plan. On May 27, 2003, the
Bankruptcy Court entered an Order (Confirmation Order) confirming the Proposed
Plan (hereafter referred to as the Approved Plan). On June 30, 2003, the
United States District Court for the Middle District of Tennessee rejected the
secured Lenders request to stay the effective date of the Approved Plan. On
July 1, 2003, the Debtors Approved Plan became effective and the Debtors
successfully emerged from bankruptcy protection. The Lenders have filed an
appeal of the Confirmation Order to the Approved Plan. The Debtors will contest
the appeal and seek to have the Bankruptcy Courts Confirmation Order affirmed on
appeal. See Note 14 for additional discussion.

The Approved Plan provides for the treatment of all of the claims subject to
compromise in the Bankruptcy Filing (see Note 4). The Approved Plan provides
for the extension of the maturity on the debt to the Lenders, a reduction of
the related interest cost on such debt, and the payment of all of the Debtors
reported liabilities. The Lenders retained their liens on substantially all of
the assets of the Company. The Approved Plan is described further in Note 14,
and a copy of the Approved Plan is included as Exhibit 2.1.

On October 15, 2002, the Company, the Lenders and the unsecured creditors filed
an agreed order with the Bankruptcy Court authorizing the use of cash
collateral and granting adequate protection payments to the Lenders. This
order, which expired May 27, 2003, authorized the Company to use cash
collateral, but provided certain restrictions on the Companys ability to
make cash disbursements. The Company was authorized to use cash collateral
solely for the

10



---



##### Table of Contents



following purposes: (i) to make cash disbursements as set forth
in a cash forecast prepared by the Company, not to exceed 5% in any four week
rolling period, (ii) to pay fees required by the Office of the United States
Trustee, (iii) to make adequate protection payments to the Lenders, and (iv) to
replace or increase certain letters of credit. The Company agreed to make
adequate protection payments to the Lenders of $1,600,000 per month beginning
with the month of August 2002, subject to maintaining a required minimum cash
balance of $12,000,000 plus the amount necessary to fund incentive bonuses
through March 31, 2003, as well as any amounts necessary to replace or increase
letters of credit. An initial payment totaling $3,200,000 for August and
September 2002, in the aggregate, was made on October 15, 2002, and additional
adequate protection payments were paid on the 15th of each successive month
through and including the last payment due June 15, 2003. Pursuant to an order
of the Bankruptcy Court, the adequate protection payments, which total
$15,794,000, will reduce the principal balance owed to the Lenders. See Note
14 for further discussion of the application of the adequate protection
payments.

Through June 30, 2003, the Debtors operated their business as a
debtor-in-possession in accordance with the applicable provisions of the
Bankruptcy Court. As a debtor-in-possession, the Company was authorized to
operate its business but was not permitted to engage in transactions outside
its ordinary course of business without the approval of the Bankruptcy Court.
Prior to the hearing, the Company did not seek to obtain debtor-in-possession
secured financing (DIP Financing). After the Approved Plans confirmation,
the Company did not obtain DIP Financing. The Companys funding of day-to-day
operations going forward and all payments required under the Approved Plan will
rely on cash flow and cash on hand as it has since the Lenders terminated the
Companys ability to access a revolving line of credit in 2000. At June 30,
2003 the Company had cash and cash equivalents of approximately $21.5 million.
The Bankruptcy Filing has had no impact on the Companys existing joint
ventures with unrelated parties.

The accompanying unaudited condensed consolidated interim financial statements
have been prepared on a going concern basis and in accordance with the American
Institute of Certified Public Accountants Statement of Position 90-7 (SOP
90-7), Financial Reporting by Entities in Reorganization Under the Bankruptcy
Code. Accordingly, these consolidated interim financial statements do not
reflect any adjustments that might result if the Company is unable to continue
as a going concern. All pre-petition liabilities subject to compromise have
been segregated in the unaudited condensed consolidated balance sheets and
classified as liabilities subject to compromise, at the estimated amount of
allowable claims. Liabilities not subject to compromise are separately
classified as current and non-current in the unaudited condensed consolidated
balance sheets. Revenues, expenses, realized gains and losses, and provisions
for losses and expenses resulting from the reorganization are reported
separately as reorganization items. Cash used for reorganization items is
disclosed separately in the unaudited condensed consolidated statements of cash
flows. Post-petition interest excluded from the statements of operations for
the three and six months ended June 30, 2003, of $6,210,000 and $12,510,000,
respectively, represents the default rate of interest pursuant to the terms
described in the Amended Credit Agreement. See Note 14 regarding the Companys
emergence from bankruptcy protection and the financial reporting of the Company
after emergence from bankruptcy protection.

11



---



##### Table of Contents



4. LIABILITIES SUBJECT TO COMPROMISE AND REORGANIZATION ITEMS

Liabilities subject to compromise refer to liabilities incurred prior to the
commencement of the Chapter 11 Cases. These liabilities consist primarily of
amounts outstanding under the Bank Credit Facility, the Government Settlement
(see Note 7), and capital leases, and also includes accounts payable, accrued
interest, amounts accrued for future lease rejections, professional fees
related to the reorganization, and other accrued expenses. Such claims remain
subject to future adjustments based on negotiations, actions of the Bankruptcy
Court, further developments with respect to disputed claims, and other events.
Payment terms for these amounts were established in the Approved Plan.

The Company received approval from the Bankruptcy Court to pay or otherwise
honor certain pre-petition liabilities, including wages and benefits of
employees, reimbursement of employee business expenses, insurance costs,
medical directors fees, utilities and patient refunds in the ordinary course of
business. The Company is also authorized to pay pre-petition liabilities to
certain vendors providing critical goods and services, provided these payments
do not exceed a predetermined amount. As a debtor-in-possession, the Company
also has the right, subject to Bankruptcy Court approval and certain other
limitations, to assume or reject executory contracts and unexpired leases. The
parties affected by these rejections may file claims with the Bankruptcy Court
in accordance with bankruptcy procedures and orders of the Bankruptcy Court in
this case. Any such damages resulting from these rejections, as determined by
the Bankruptcy Court, will be treated as general unsecured claims under the
Approved Plan.

The principal categories of claims classified as liabilities subject to
compromise under reorganization proceedings are as follows:

|                                                    |                                         |   |             |             | 
|--------------------------------------------------- | --------------------------------------- | - | ----------- | ----------- | 
|Pre-petition accounts payable                       |                                         | $ | 19,713,000  |            
|State income taxes payable                          |                                         |   | 394,000     |            
|Other accruals                                      |                                         |   | 5,004,000   |            
|Accrued interest                                    |                                         |   | 1,260,000   |            
|Accrued professional fees related to reorganization |                                         |   | 2,014,000   |            
|Accrual for future lease rejection damages          |                                         |   | 1,317,000   |            
|Other long-term debt and liabilities                |                                         |   | 1,847,000   |            
|Government settlement, including interest           |                                         |   | 4,337,000   |            
|Bank credit facility                                |                                         |   | 278,705,000 |            
|Adequate protection payments                        |                                         |   | (15,794,000 | )          
|                                                    |                                         |   |             |            
|                                                    | Total liabilities subject to compromise |   | $           | 298,797,000 | 
|                                                    |                                         |   |             |            

Reorganization items represent expenses that are incurred by the Company as a
result of reorganization under Chapter 11 of the Federal Bankruptcy Code.
Reorganization items for the three and six months ended June 30, 2003 were
$2,004,000 and $2,856,000, respectively, and are comprised primarily of
professional fees.

See Note 14 for additional information regarding the classification of
liabilities subject to compromise after the Companys emergence from bankruptcy
protection.

12



---



##### Table of Contents



5. DEBTORS AND NON-DEBTORS FINANCIAL STATEMENTS

The Debtors filed voluntary petitions for relief to reorganize under Chapter 11
of the U.S. Bankruptcy Code. The joint ventures (both consolidated and
non-consolidated) are not part of the Bankruptcy Filing.

In accordance with SOP 90-7, the Company is presenting the following condensed
combining financial statements as of and for the six months ended June 30,
2003:

13



---



##### Table of Contents



American HomePatient, Inc. and Subsidiaries




Condensed Combining Balance Sheets as of June 30, 2003


|                                               |                                                           |                                                      |                              |              |             |             |             |            |            |            |             |              |             |             | 
|---------------------------------------------- | --------------------------------------------------------- | ---------------------------------------------------- | ---------------------------- | ------------ | ----------- | ----------- | ----------- | ---------- | ---------- | ---------- | ----------- | ------------ | ----------- | ----------- | 
|                                               |                                                           |                                                      |                              |              | Debtors     |             | Non-Debtors |            | Combined  
|                                               |                                                           |                                                      |                              |              |             |             |             |            |           
|ASSETS                                         |                                                           |                                                      |                              |              |             |             |             |            |            |            |             |             
|CURRENT ASSETS:                                |                                                           |                                                      |                              |              |             |             |             |            |            |            |             |             
|                                               | Cash and cash equivalents                                 |                                                      | $                            | 21,483,000   |             |             | $           | 48,000     |            |            | $           | 21,531,000   |            
|                                               | Restricted cash                                           |                                                      |                              | 467,000      |             |             |             |           |            |            |             | 467,000      |            
|                                               | Accounts receivable, less allowance for doubtful accounts |                                                      |                              | 55,522,000   |             |             |             | 462,000    |            |            |             | 55,984,000   |            
|                                               | Inventories, net of inventory reserves                    |                                                      |                              | 15,006,000   |             |             |             | 42,000     |            |            |             | 15,048,000   |            
|                                               | Prepaid expenses and other current assets                 |                                                      |                              | 2,689,000    |             |             |             | 6,000      |            |            |             | 2,695,000    |            
|                                               |                                                           |                                                      |                              |              |             |             |             |            |            |            |             |              |            
|                                               |                                                           |                                                      | Total current assets         |              |             | 95,167,000  |             |            |            | 558,000    |             |              |             | 95,725,000  | 
|                                               |                                                           |                                                      |                              |              |             |             |             |            |            |            |             |              |            
|PROPERTY AND EQUIPMENT, at cost:               |                                                           |                                                      | 168,787,000                  |              |             |             | 1,493,000   |            |            |            | 170,280,000 |             
|                                               | Less accumulated depreciation and amortization            |                                                      |                              | (116,768,000 | )           |             |             | (896,000   | )          |            |             | (117,664,000 | )          
|                                               |                                                           |                                                      |                              |              |             |             |             |            |            |            |             |              |            
|                                               |                                                           |                                                      | Property and equipment, net  |              |             | 52,019,000  |             |            |            | 597,000    |             |              |             | 52,616,000  | 
|                                               |                                                           |                                                      |                              |              |             |             |             |            |            |            |             |              |            
|OTHER ASSETS:                                  |                                                           |                                                      |                              |              |             |             |             |            |            |            |             |             
|                                               | Goodwill, net                                             |                                                      |                              | 121,214,000  |             |             |             |           |            |            |             | 121,214,000  |            
|                                               | Investment in joint ventures                              |                                                      |                              | (1,220,000   | )           |             |             | 10,170,000 |            |            |             | 8,950,000    |            
|                                               | Other assets                                              |                                                      |                              | 12,660,000   |             |             |             | 1,000      |            |            |             | 12,661,000   |            
|                                               |                                                           |                                                      |                              |              |             |             |             |            |            |            |             |              |            
|                                               |                                                           |                                                      | Total other assets           |              |             | 132,654,000 |             |            |            | 10,171,000 |             |              |             | 142,825,000 | 
|                                               |                                                           |                                                      |                              |              |             |             |             |            |            |            |             |              |            
|                                               |                                                           | TOTAL ASSETS                                         |                              | $            | 279,840,000 |             |             | $          | 11,326,000 |            |             | $            | 291,166,000 |            
|                                               |                                                           |                                                      |                              |              |             |             |             |            |            |            |             |              |            
|LIABILITIES AND SHAREHOLDERS (DEFICIT) EQUITY |                                                           |                                                      |                              |              |             |             |             |            |            |            |             |             
|CURRENT LIABILITIES:                           |                                                           |                                                      |                              |              |             |             |             |            |            |            |             |             
|                                               | Accounts payable                                          |                                                      | $                            | 13,701,000   |             |             | $           |           |            |            | $           | 13,701,000   |            
|                                               | Other payables                                            |                                                      |                              | 1,896,000    |             |             |             | 1,000      |            |            |             | 1,897,000    |            
|                                               | Accrued expenses:                                         |                                                      |                              |              |             |             |             |            |            |            |             |              |            
|                                               |                                                           | Payroll and related benefits                         |                              |              | 6,766,000   |             |             |            | 26,000     |            |             |              | 6,792,000   |            
|                                               |                                                           | Insurance, including self-insurance reserves         |                              |              | 6,507,000   |             |             |            |           |            |             |              | 6,507,000   |            
|                                               |                                                           | Other                                                |                              |              | 1,607,000   |             |             |            | 10,000     |            |             |              | 1,617,000   |            
|                                               |                                                           |                                                      |                              |              |             |             |             |            |            |            |             |              |            
|                                               |                                                           |                                                      | Total current liabilities    |              |             | 30,477,000  |             |            |            | 37,000     |             |              |             | 30,514,000  | 
|                                               |                                                           |                                                      |                              |              |             |             |             |            |            |            |             |              |            
|NONCURRENT LIABILITIES:                        |                                                           |                                                      |                              |              |             |             |             |            |            |            |             |             
|                                               | Minority interest                                         |                                                      |                              |             |             |             |             | 486,000    |            |            |             | 486,000      |            
|                                               | Other noncurrent liabilities                              |                                                      |                              | 106,000      |             |             |             |           |            |            |             | 106,000      |            
|                                               |                                                           |                                                      |                              |              |             |             |             |            |            |            |             |              |            
|                                               |                                                           |                                                      | Total noncurrent liabilities |              |             | 106,000     |             |            |            | 486,000    |             |              |             | 592,000     | 
|                                               |                                                           |                                                      |                              |              |             |             |             |            |            |            |             |              |            
|LIABILITIES SUBJECT TO COMPROMISE:             |                                                           |                                                      | 298,797,000                  |              |             |             |            |            |            |            | 298,797,000 |             
|                                              
|SHAREHOLDERS (DEFICIT) EQUITY                 |                                                           |                                                      | (49,540,000                  | )            |             |             | 10,803,000  |            |            |            | (38,737,000 | )           
|                                               |                                                           |                                                      |                              |              |             |             |             |            |            |            |             |              |            
|                                               |                                                           | TOTAL LIABILITIES AND SHAREHOLDERS (DEFICIT) EQUITY |                              | $            | 279,840,000 |             |             | $          | 11,326,000 |            |             | $            | 291,166,000 |            
|                                               |                                                           |                                                      |                              |              |             |             |             |            |            |            |             |              |            

14



---



##### Table of Contents



American HomePatient, Inc. and Subsidiaries




Condensed Combining Statements of Operations


for the Six Months Ended June 30, 2003


|                                                                    |                                                                             |                         |                |            |             |             |             |            |          |           |            |            |             |             | 
|------------------------------------------------------------------- | --------------------------------------------------------------------------- | ----------------------- | -------------- | ---------- | ----------- | ----------- | ----------- | ---------- | -------- | --------- | ---------- | ---------- | ----------- | ----------- | 
|                                                                    |                                                                             |                         |                |            | Debtors     |             | Non-Debtors |            | Combined
|                                                                    |                                                                             |                         |                |            |             |             |             |            |         
|REVENUES:                                                           |                                                                             |                         |                |            |             |             |             |            |          |           |            |           
|                                                                    | Sales and related service revenues                                          |                         | $              | 72,127,000 |             |             | $           | 473,000    |          |           | $          | 72,600,000 |            
|                                                                    | Rentals and other revenues                                                  |                         |                | 91,623,000 |             |             |             | 1,148,000  |          |           |            | 92,771,000 |            
|                                                                    |                                                                             |                         |                |            |             |             |             |            |          |           |            |            |            
|                                                                    |                                                                             |                         | Total revenues |            |             | 163,750,000 |             |            |          | 1,621,000 |            |            |             | 165,371,000 | 
|                                                                    |                                                                             |                         |                |            |             |             |             |            |          |           |            |            |            
|EXPENSES:                                                           |                                                                             |                         |                |            |             |             |             |            |          |           |            |           
|                                                                    | Cost of sales and related services                                          |                         |                | 34,485,000 |             |             |             | 257,000    |          |           |            | 34,742,000 |            
|                                                                    | Cost of rentals and other revenues, including rental equipment depreciation |                         |                | 17,223,000 |             |             |             | 173,000    |          |           |            | 17,396,000 |            
|                                                                    | Operating, including bad debt expense                                       |                         |                | 92,484,000 |             |             |             | 770,000    |          |           |            | 93,254,000 |            
|                                                                    | General and administrative                                                  |                         |                | 8,672,000  |             |             |             |           |          |           |            | 8,672,000  |            
|                                                                    | Earnings from joint ventures                                                |                         |                | (1,083,000 | )           |             |             | (1,338,000 | )        |           |            | (2,421,000 | )          
|                                                                    | Depreciation, excluding rental equipment, and amortization                  |                         |                | 1,768,000  |             |             |             | 3,000      |          |           |            | 1,771,000  |            
|                                                                    | Interest income, net                                                        |                         |                | (50,000    | )           |             |             |           |          |           |            | (50,000    | )          
|                                                                    | Other expense, net                                                          |                         |                | 94,000     |             |             |             |           |          |           |            | 94,000     |            
|                                                                    |                                                                             |                         |                |            |             |             |             |            |          |           |            |            |            
|                                                                    |                                                                             | Total expenses (income) |                |            | 153,593,000 |             |             |            | (135,000 | )         |            |            | 153,458,000 |            
|                                                                    |                                                                             |                         |                |            |             |             |             |            |          |           |            |            |            
|INCOME FROM OPERATIONS BEFORE REORGANIZATION ITEMS AND INCOME TAXES |                                                                             |                         | 10,157,000     |            |             |             | 1,756,000   |            |          |           | 11,913,000 |           
|REORGANIZATION ITEMS                                                |                                                                             |                         | 2,856,000      |            |             |             |            |            |          |           | 2,856,000  |           
|                                                                    |                                                                             |                         |                |            |             |             |             |            |          |           |            |            |            
|INCOME FROM OPERATIONS BEFORE INCOME TAXES                          |                                                                             |                         | 7,301,000      |            |             |             | 1,756,000   |            |          |           | 9,057,000  |           
|PROVISION FOR INCOME TAXES                                          |                                                                             |                         | 200,000        |            |             |             |            |            |          |           | 200,000    |           
|                                                                    |                                                                             |                         |                |            |             |             |             |            |          |           |            |            |            
|NET INCOME                                                          |                                                                             | $                       | 7,101,000      |            |             | $           | 1,756,000   |            |          | $         | 8,857,000  |           
|                                                                    |                                                                             |                         |                |            |             |             |             |            |          |           |            |            |            

15



---



##### Table of Contents



American HomePatient, Inc. and Subsidiaries




Condensed Combining Statements of Cash Flows


for the Six Months Ended June 30, 2003


|                                               |                                                                                       |                                                       |                                       |                                                     |            |             |            |             |            |          |            |             |            |             |            |  
|---------------------------------------------- | ------------------------------------------------------------------------------------- | ----------------------------------------------------- | ------------------------------------- | --------------------------------------------------- | ---------- | ----------- | ---------- | ----------- | ---------- | -------- | ---------- | ----------- | ---------- | ----------- | ---------- | -
|                                               |                                                                                       |                                                       |                                       |                                                     |            | Debtors     |            | Non-Debtors |            | Combined
|                                               |                                                                                       |                                                       |                                       |                                                     |            |             |            |             |            |         
|CASH FLOWS FROM OPERATING ACTIVITIES:          |                                                                                       |                                                       |                                       |                                                     |            |             |            |             |            |          |            |            
|                                               | Net income                                                                            |                                                       | $                                     | 7,101,000                                           |            |             | $          | 1,756,000   |            |          | $          | 8,857,000   |           
|                                               | Adjustments to reconcile net income to net cash provided by
operating activities:     |                                                       |                                       |                                                     |            |             |            |             |            |          |            |             |           
|                                               |                                                                                       | Depreciation and amortization                         |                                       |                                                     | 11,481,000 |             |            |             | 119,000    |          |            |             | 11,600,000 |            
|                                               |                                                                                       | Provision for doubtful accounts                       |                                       |                                                     | (3,307,000 | )           |            |             | 1,000      |          |            |             | (3,306,000 | )          
|                                               |                                                                                       | Provision for inventory                               |                                       |                                                     | (21,000    | )           |            |             |           |          |            |             | (21,000    | )          
|                                               |                                                                                       | Equity in earnings of unconsolidated joint ventures   |                                       |                                                     |           |             |            |             | (1,338,000 | )        |            |             | (1,338,000 | )          
|                                               |                                                                                       | Minority interest                                     |                                       |                                                     |           |             |            |             | 179,000    |          |            |             | 179,000    |            
|                                               |                                                                                       | Reorganization items                                  |                                       |                                                     | 2,856,000  |             |            |             |           |          |            |             | 2,856,000  |            
|                                               |                                                                                       | Reorganization items paid                             |                                       |                                                     | (2,660,000 | )           |            |             |           |          |            |             | (2,660,000 | )          
|                                               | Change in assets and liabilities:                                                     |                                                       |                                       |                                                     |            |             |            |             |            |          |            |             |           
|                                               |                                                                                       | Accounts receivable                                   |                                       |                                                     | 2,817,000  |             |            |             | (58,000    | )        |            |             | 2,759,000  |            
|                                               |                                                                                       | Inventories                                           |                                       |                                                     | 1,481,000  |             |            |             | 57,000     |          |            |             | 1,538,000  |            
|                                               |                                                                                       | Prepaid expenses and other current assets             |                                       |                                                     | (413,000   | )           |            |             | (6,000     | )        |            |             | (419,000   | )          
|                                               |                                                                                       | Accounts payable, other payables and accrued expenses |                                       |                                                     | (1,068,000 | )           |            |             | (3,000     | )        |            |             | (1,071,000 | )          
|                                               |                                                                                       | Other assets and liabilities                          |                                       |                                                     | (92,000    | )           |            |             | (1,000     | )        |            |             | (93,000    | )          
|                                               |                                                                                       | Other noncurrent liabilities                          |                                       |                                                     | (15,000    | )           |            |             |           |          |            |             | (15,000    | )          
|                                               |                                                                                       |                                                       |                                       |                                                     |            |             |            |             |            |          |            |             |           
|                                               |                                                                                       |                                                       |                                       | Net cash provided by (used in) operating activities |            |             | 18,160,000 |             |            |          | (706,000   | )           |            |             | 18,866,000 |  
|                                               |                                                                                       |                                                       |                                       |                                                     |            |             |            |             |            |          |            |             |           
|CASH FLOWS FROM INVESTING ACTIVITIES:          |                                                                                       |                                                       |                                       |                                                     |            |             |            |             |            |          |            |            
|                                               | Additions to property and equipment, net                                              |                                                       |                                       | (13,642,000                                         | )          |             |            | (140,000    | )          |          |            | (13,782,000 | )         
|                                               | Distributions and loan payments from (advances to)
unconsolidated joint ventures, net |                                                       |                                       | 2,615,000                                           |            |             |            | (412,000    | )          |          |            | 2,203,000   |           
|                                               |                                                                                       |                                                       |                                       |                                                     |            |             |            |             |            |          |            |             |           
|                                               |                                                                                       |                                                       | Net cash used in investing activities |                                                     |            | (11,027,000 | )          |             |            | (552,000 | )          |             | $          | (11,579,000 | )         
|                                               |                                                                                       |                                                       |                                       |                                                     |            |             |            |             |            |          |            |             |           
|CASH FLOWS FROM FINANCING ACTIVITIES:          |                                                                                       |                                                       |                                       |                                                     |            |             |            |             |            |          |            |            
|                                               | Principal payments on long-term debt and capital leases                               |                                                       |                                       | (226,000                                            | )          |             |            |            |            |          |            | (226,000    | )         
|                                               | Adequate protection payments                                                          |                                                       |                                       | (7,794,00                                           | )          |             |            |            |            |          |            | (7,794,000  | )         
|                                               | Distributions to minority interest owners                                             |                                                       |                                       |                                                    |            |             |            | (163,000    | )          |          |            | (163,000    | )         
|                                               | Restricted cash                                                                       |                                                       |                                       | (400,000                                            | )          |             |            |            |            |          |            | (400,000    | )         
|                                               |                                                                                       |                                                       |                                       |                                                     |            |             |            |             |            |          |            |             |           
|                                               |                                                                                       |                                                       |                                       | Net cash used in financing activities               |            |             | (8,420,000 | )           |            |          | (163,000   | )           |            |             | (8,583,000 | )
|                                               |                                                                                       |                                                       |                                       |                                                     |            |             |            |             |            |          |            |             |           
|DECREASE IN CASH AND CASH EQUIVALENTS          |                                                                                       |                                                       | (1,287,000                            | )                                                   |            |             | (9,000     | )           |            |          | (1,296,000 | )          
|CASH AND CASH EQUIVALENTS, beginning of period |                                                                                       |                                                       | 22,770,000                            |                                                     |            |             | 57,000     |             |            |          | 22,827,000 |            
|                                               |                                                                                       |                                                       |                                       |                                                     |            |             |            |             |            |          |            |             |           
|CASH AND CASH EQUIVALENTS, end of period       |                                                                                       | $                                                     | 21,483,000                            |                                                     |            | $           | 48,000     |             |            | $        | 21,531,000 |            
|                                               |                                                                                       |                                                       |                                       |                                                     |            |             |            |             |            |          |            |             |           
|SUPPLEMENTAL INFORMATION:                      |                                                                                       |                                                       |                                       |                                                     |            |             |            |             |            |          |            |            
|                                               | Cash payments of interest                                                             |                                                       | $                                     | 49,000                                              |            |             | $          |            |            |          | $          | 49,000      |           
|                                               |                                                                                       |                                                       |                                       |                                                     |            |             |            |             |            |          |            |             |           
|                                               | Cash payments of income taxes                                                         |                                                       | $                                     | 105,000                                             |            |             | $          |            |            |          | $          | 105,000     |           
|                                               |                                                                                       |                                                       |                                       |                                                     |            |             |            |             |            |          |            |             |           

16



---



##### Table of Contents



6. GOING CONCERN

The accompanying financial statements have been prepared assuming that the
Company will continue as a going concern. The Company had net income of
$4,520,000 and $8,857,000 for the three and six months ended June 30, 2003,
respectively, and incurred net losses of $64,000, $66,941,000 and $61,154,000
for the three and six months ended June 30, 2002 and the year ended December
31, 2002, respectively. The Company has a shareholders deficit of $38,737,000
at June 30, 2003. The Company has substantial debt balances related to the
Amended Credit Agreement, of which $278,705,000 was due on or before December
31, 2002 until the maturity was modified pursuant to the Approved Plan. This
amount is included in liabilities subject to compromise as of June 30, 2003.
See Note 3 and Note 14 for further information related to the Bankruptcy
Filing. These matters among others raise substantial doubt about the Companys
ability to continue as a going concern. The accompanying financial statements
do not include any adjustments of recorded asset carrying amounts or the
amounts and classification of liabilities that might result should the Company
be unable to continue as a going concern.

The Companys Approved Plan provides for the extension of the maturity on the
debt to the Lenders, a reduction of the related interest cost on such debt, and
the payment of all of its reported liabilities. The Lenders retained their
liens on substantially all of the assets of the Company. Under the Approved
Plan, the Company will continue to be highly leveraged and subject to
substantial interest costs. In addition, the Company intends to improve
financial performance through consolidating operations, stabilizing and
increasing profitable revenues, decreasing and controlling operating expenses
and improving accounts receivable performance. The Company is unable to
predict whether it will be able to successfully execute the operational results
contemplated by the Approved Plan. If the Company is unable to continue to
improve its operations, its financial position, results of operations and cash
flows would be impacted adversely.

Managements cash flow projections and related operating plans indicate that
the Company can operate on its existing cash and cash flow and make all
payments provided for in its Approved Plan. The Company has operated in this
manner since the Bankruptcy Filing. However, as with all projections, there
can be no guarantee that managements projections will be achieved.

7. GOVERNMENT INVESTIGATION AND LITIGATION

Government Settlement.On June 11, 2001, a settlement agreement (the
Government Settlement) was entered among the Company, the United States of
America, acting through the United States Department of Justice (DOJ) and on
behalf of the Office of Inspector General of the Department of Health and Human
Services (OIG) and the TRICARE Management Activity, and a former Company
employee, as relator. The Government Settlement was approved by the United
States District Court for the Western District of Kentucky, the court in which
the relators false claim action was filed. The Government Settlement covers
alleged improprieties by the Company during the period from January 1, 1995
through December 31, 1998, including allegedly improper billing activities and
allegedly improper remuneration to and contracts with physicians, hospitals and
other healthcare providers. Pursuant to the Government Settlement, the Company
made an initial payment of $3,000,000 in the second quarter of 2001 and agreed
to make additional payments in the principal amount of $4,000,000, together
with interest on this amount, in

17



---



##### Table of Contents



installments due at various times until March
2006. The Company also agreed to pay the
relators attorneys fees and expenses. Pursuant to the Approved Plan, amounts
owed pursuant to the Government Settlement will be paid in full in accordance
with the Government Settlement. The Company has reserved $4,337,000 for its
future obligations pursuant to the Government Settlement.

Other Claims and Litigation.Other than the Government Settlement, all
other claims and litigation described below are disputed by the Company. To
the extent the Bankruptcy Court ultimately determines that any of the parties
has a valid claim pursuant to the Approved Plan it will be paid as a general
unsecured claim.

The relator in the false claim action giving rise to the Government Settlement
also asserted in his amended complaint that the Company discriminated against
him because of his reports of alleged wrong-doing to the government. The
relator filed a claim in the Companys bankruptcy proceeding for damages
allegedly sustained as a result of the alleged discrimination. The Company has
objected to that claim.

The Company also was named as a defendant in two other False Claims Act cases
filed prior to the Companys bankruptcy. In each of those cases, the DOJ
declined to intervene and both cases were subsequently dismissed in March 2001.
The first of these cases, United States ex rel. Kirk S. Corsello v. Lincare, et
al. (N.D. Ga.), was dismissed with prejudice on motion of the Company on March
9, 2001. The appeal of that dismissal was argued in November 2001; however, in
December 2001 the Court of Appeals for the Eleventh Circuit dismissed the
appeal on jurisdictional grounds and returned the case to the trial court. In
January 2002, one of the other defendants filed a Motion for Reconsideration
with the Court of Appeals, and the Court of Appeals denied the motion on July
10, 2002. On August 5, 2002 the Company filed a Notice of Bankruptcy which
stayed the proceedings as to the Company. Mr. Corsellos qui tam complaint
alleged that the Company and numerous other unrelated defendants, including
other large DME suppliers, engaged in a kickback scheme to provide free or
below market value equipment and medicine to physicians who would in turn refer
patients to the defendants in violation of the False Claims Act. The other
case, United States ex rel. Alan D. Hutchison v. Respironics, et al. (S.D. NY
and N.D. Ga.), was dismissed without prejudice on Mr. Hutchisons own motion on
March 22, 2001. Mr. Hutchisons qui tam complaint alleged that the Company and
numerous other unrelated defendants filed false claims with Medicare for
ventilators that the defendants allegedly knew were not medically necessary.
To the Companys knowledge, neither Corsello or Hutchison filed a claim in the
Companys bankruptcy.

The Company was informed in May 2001 that the United States was investigating
its conduct during periods after December 31, 1998, and the Company believes
that this investigation was prompted by another qui tam complaint against the
Company under the False Claims Act. The Company has not seen a complaint in
this action and, to the Companys knowledge, no claim was filed against the
Company by the United States or any party purporting to act on its behalf for
any amounts other than those owed pursuant to the Government Settlement.

There can be no assurances as to the final outcome of any pending False Claims
Act lawsuits. Possible outcomes include, among other things, the repayment of
reimbursements previously received by the Company related to improperly billed
claims, the imposition of fines or penalties, and the suspension or exclusion
of the Company from participation in the Medicare, Medicaid and other
government reimbursement programs. Other than the $4,337,000 reserve for
future

18



---



##### Table of Contents



obligations pursuant to the Government Settlement, the Company has not recorded
any reserves related to the unsettled government investigations. The outcome
of any pending lawsuits or future settlements could have a material adverse
effect on the Company.

The Company is a party to other legal proceedings incidental to its business.
In the opinion of management, any ultimate liability with respect to these
other actions will not have a material adverse effect on its financial position
or results of operations.

8. RELATED PARTY TRANSACTIONS

A partner in the law firm of Harwell Howard Hyne Gabbert & Manner, P.C.
(H3GM), which the Company engaged during 2003 and 2002 to render legal advice
in a variety of activities, was a director of the Company until July 2002. The
Company paid H3GM $224,000, $339,000, $195,000 and $391,000 during the three
and six months ended June 30, 2003 and the three and six months ended June 30,
2002, respectively.

The Company maintains an employee benefit trust for the purpose of paying
health insurance claims for its employees. The trust was established in June
2002 and was funded with an initial deposit of $0.5 million in July 2002.
Disbursements from the trust began in late July 2002. The Company deposits
funds into the trust on an as needed basis to pay claims.

9. SALE OF ASSETS OF CENTER

In the quarter ended March 31, 2002, the Company recorded a pre-tax gain of
approximately $0.7 million related to the sale of the assets of an infusion
business and nursing agency (collectively , the Center). Effective March 19,
2002 substantially all of the assets of the Center were sold for approximately
$1.3 million in cash. During the six months ended June 30, 2002, the Center
generated approximately $1.9 million in total revenues. The proceeds of this
sale were used to pay down debt under the Companys Bank Credit Facility.

10. EARNINGS PER SHARE

Under the standards established by Statement of Financial Accounting Standards
No. 128, Earnings Per Share, earnings per share is measured at two levels:
basic earnings per share and diluted earnings per share. Basic earnings per
share is computed by dividing net income (loss) by the weighted average number
of common shares outstanding during the year. Diluted earnings per share is
computed by dividing net income (loss) by the weighted average number of common
shares after considering the additional dilution related to convertible
preferred stock, convertible debt, options and warrants. In computing diluted
earnings per share, the outstanding stock warrants and stock options are
considered dilutive using the treasury stock method. For the three months
ended June 30, 2003 and 2002, and for the six months ended June 30, 2003 and
2002 approximately 1,379,000, 4,125,000, 1,817,000 and 6,036,000 shares,
respectively, were attributable to the exercise of outstanding options and were
excluded from the calculation of diluted earnings per share because the effect
was antidilutive.

19



---



##### Table of Contents



The following information is necessary to calculate earnings per share for the
periods presented:

|                                                                                   |           |   |                             |      |                           |   |            |   |      |   |            |      |  |   |             |       |  
|---------------------------------------------------------------------------------- | --------- | - | --------------------------- | ---- | ------------------------- | - | ---------- | - | ---- | - | ---------- | ---- |  | - | ----------- | ----- | -
|                                                                                   |           |   | Three Months Ended June 30, |      | Six Months Ended June 30,
|                                                                                   |           |   |                             |      |                          
|                                                                                   |           |   | 2003                        |      | 2002                      |   | 2003       |   | 2002
|                                                                                   |           |   |                             |      |                           |   |            |   |     
|Income (loss) before cumulative effect of
change in accounting principle           |           | $ | 4,520,000                   |      |                           | $ | (64,000    | ) |      | $ | 8,857,000  |      |  | $ | 1,544,000   |      
|Cumulative effect of change in accounting
principle                                |           |   |                            |      |                           |   |           |   |      |   |           |      |  |   | (68,485,000 | )    
|                                                                                   |           |   |                             |      |                           |   |            |   |      |   |            |      |  |   |             |      
|Net income (loss)                                                                  |           | $ | 4,520,000                   |      |                           | $ | (64,000    | ) |      | $ | 8,857,000  |      |  | $ | (66,941,000 | )    
|                                                                                   |           |   |                             |      |                           |   |            |   |      |   |            |      |  |   |             |      
|Weighted average common shares outstanding                                         |           |   | 16,367,000                  |      |                           |   | 16,367,000 |   |      |   | 16,367,000 |      |  |   | 16,349,000  |      
|Effect of dilutive options and warrants                                            |           |   | 2,468,000                   |      |                           |   |           |   |      |   | 2,296,000  |      |  |   | 2,339,000   |      
|                                                                                   |           |   |                             |      |                           |   |            |   |      |   |            |      |  |   |             |      
|Adjusted diluted common shares outstanding                                         |           |   | 18,835,000                  |      |                           |   | 16,367,000 |   |      |   | 18,663,000 |      |  |   | 18,688,000  |      
|                                                                                   |           |   |                             |      |                           |   |            |   |      |   |            |      |  |   |             |      
|Income per common share before cumulative
effect of change in accounting principle |           |   |                             |      |                           |   |            |   |      |   |            |      |  |   |             |      
|                                                                                   |  Basic   |   | $                           | 0.28 |                           |   | $          |  |      |   | $          | 0.54 |  |   | $           | 0.09  |  
|                                                                                   |           |   |                             |      |                           |   |            |   |      |   |            |      |  |   |             |      
|                                                                                   |  Diluted |   | $                           | 0.24 |                           |   | $          |  |      |   | $          | 0.47 |  |   | $           | 0.08  |  
|                                                                                   |           |   |                             |      |                           |   |            |   |      |   |            |      |  |   |             |      
|Cumulative effect of change in accounting
principle per common share               |           |   |                             |      |                           |   |            |   |      |   |            |      |  |   |             |      
|                                                                                   |  Basic   |   | $                           |     |                           |   | $          |  |      |   | $          |     |  |   | $           | (4.19 | )
|                                                                                   |           |   |                             |      |                           |   |            |   |      |   |            |      |  |   |             |      
|                                                                                   |  Diluted |   | $                           |     |                           |   | $          |  |      |   | $          |     |  |   | $           | (3.66 | )
|                                                                                   |           |   |                             |      |                           |   |            |   |      |   |            |      |  |   |             |      
|Net income (loss) per common share                                                 |           |   |                             |      |                           |   |            |   |      |   |            |      |  |   |             |      
|                                                                                   |  Basic   |   | $                           | 0.28 |                           |   | $          |  |      |   | $          | 0.54 |  |   | $           | (4.10 | )
|                                                                                   |           |   |                             |      |                           |   |            |   |      |   |            |      |  |   |             |      
|                                                                                   |  Diluted |   | $                           | 0.24 |                           |   | $          |  |      |   | $          | 0.47 |  |   | $           | (3.58 | )
|                                                                                   |           |   |                             |      |                           |   |            |   |      |   |            |      |  |   |             |      

11. RECENT ACCOUNTING PRONOUNCEMENTS

In June 2001, the Financial Accounting Standards Board (FASB) issued
Statement of Financial Accounting Standards No. 141, Business Combinations
(SFAS No. 141) and Statement of Financial Accounting Standards No. 142,
Goodwill and Other Intangible Assets (SFAS No. 142). SFAS No. 141 requires
that the purchase method of accounting be used for all business combinations
initiated after June 30, 2001. SFAS No. 141 also specifies criteria which
intangible assets acquired in a purchase method business combination must meet
to be recognized and reported apart from goodwill. The Company adopted SFAS
No. 141 effective July 1, 2001. See Note 12 Adoption of SFAS No. 142 for
disclosure of the impact of SFAS No. 142. The Company adopted SFAS No. 142 on
January 1, 2002.

In June 2001, the FASB issued Statement of Financial Accounting Standards No.
143, Accounting for Asset Retirement Obligations (SFAS No. 143) effective
for fiscal years beginning after June 15, 2002. SFAS No. 143 requires that a
liability for an asset retirement obligation be recognized in the period in
which it is incurred if a reasonable estimate of fair value can be made. The
Companys January 1, 2003 adoption of SFAS No. 143 did not have a material
impact on its financial position or results of operations.

In August 2001, the FASB issued Statement of Financial Accounting Standards No.
144, Accounting for the Impairment or Disposal of Long-Lived Assets (SFAS
No. 144) effective for

20



---



##### Table of Contents



fiscal years beginning after December 15, 2001. SFAS
No. 144 establishes a single accounting model for long-lived assets to be
disposed of by sale, whether previously held and used or newly acquired, and
broadens the presentation of discontinued operations to include more disposal
transactions. The Companys January 1, 2002 adoption of SFAS No. 144 did not
have a material impact on its financial position or results of operations.

In April 2002, the FASB issued Statement of Financial Accounting Standards No.
145, Rescission of FASB Statement No. 4, 44, and 64, Amendment of FASB
Statement No. 13, and Technical Corrections (SFAS No. 145). SFAS No. 145
rescinds SFAS No. 4, Reporting Gains and Losses from Extinguishment of Debt,
and an amendment of that Statement, SFAS No. 64, Extinguishment of Debt Made
to Satisfy Sinking-Fund Requirements. SFAS No. 145 also rescinds SFAS No. 44,
Accounting for Intangible Assets of Motor Carriers. SFAS No. 145 amends SFAS
No. 13, Accounting for Leases, to eliminate an inconsistency between the
required accounting for sale-leaseback transactions and the required accounting
for certain lease modifications that have economic effects that are similar to
sale-leaseback transactions. This Statement also makes several technical
corrections and clarifications to other existing authoritative pronouncements.
The provisions of this Statement related to the rescission of SFAS No. 4 are
effective for fiscal years beginning after May 15, 2002. The provisions of
this Statement related to SFAS No. 13 are effective for transactions occurring
after May 15, 2002. All other provisions of this Statement are effective for
financial statements issued on or after May 15, 2002. The Companys adoption
of the provisions of SFAS No. 145 which were effective for transactions after
May 15, 2002 did not have a material effect on its financial statements. The
Companys January 1, 2003 adoption of the remaining provisions of SFAS No. 145
did not have a material impact on its financial position or results of
operations.

In June 2002, the FASB issued Statement of Financial Accounting Standards No.
146, Accounting for Costs Associated with Exit or Disposal Activities (SFAS
No. 146) effective for exit or disposal activities that are initiated after
December 31, 2002. SFAS No. 146 addresses financial accounting and reporting
for costs associated with exit or disposal activities and nullifies Emerging
Issues Task Force Issue No. 94-3, Liability Recognition for Certain Employee
Termination Benefits and Other Costs to Exit an Activity (including Certain
Costs Incurred in a Restructuring)(Issue 94-3). The principal difference
between SFAS No. 146 and Issue 94-3 relates to the requirements for recognition
of a liability for a cost associated with an exit or disposal activity. SFAS
No. 146 requires that a liability for a cost associated with an exit or
disposal activity be recognized when the liability is incurred. Under Issue
94-3, a liability for an exit cost as defined in Issue 94-3 was recognized at
the date of an entitys commitment to an exit plan. The Companys January 1,
2003 adoption of SFAS No. 146 did not have a material impact on its financial
position or results of operations.

In December 2002, the FASB issued Statement of Financial Accounting Standards
No. 148, Accounting for Stock-Based Compensation-Transition and Disclosure-an
amendment of FASB Statement No. 123 (SFAS No. 148), which amends SFAS No.
123, Accounting for Stock-Based Compensation, to provide alternative methods
of transition for a voluntary change to the fair value based method of
accounting for stock-based employee compensation. In addition, this Statement
amends the disclosure requirements of SFAS No. 123 to require prominent
disclosures in both annual and interim financial statements about the method of
accounting for stock-based
employee compensation and the effect of the method used on reported results.
The disclosure provisions of this Statement are effective for financial
statements for annual and interim periods

21



---



##### Table of Contents



beginning after December 15, 2002.
The Company is currently assessing the three alternative methods of transition
for a voluntary change to the fair value based method of accounting for
stock-based employee compensation included in this Statement. See Note 13 for
further discussion.

In November 2002, the FASB issued Interpretation No. 45, Guarantors
Accounting and Disclosure Requirements for Guarantees, Including Indirect
Guarantees of Indebtedness of Others, an Interpretation of FASB Statements No.
5, 57, and 107 and Rescission of FASB Interpretation No. 34 (FIN No. 45).
This Interpretation requires guarantors to account at fair value for and
disclose certain types of guarantees. The Interpretations disclosure
requirements were effective for the Companys year ended December 31, 2002; the
Interpretations accounting requirements are effective for guarantees issued or
modified after December 31, 2002. The Companys adoption of this
Interpretations accounting requirements did not have a material impact on its
financial position or results of operations.

In January, 2003, the FASB issued Interpretation No. 46, Consolidation of
Variable Interest Entities (FIN No. 46). This Interpretation requires
consolidation of variable interest entities (VIE) (formerly referred to as
special purpose entities) if certain conditions are met. The Interpretation
applies immediately to VIEs created after January 31, 2003, and to variable
interests obtained in VIEs after January 31, 2003. Effective with the quarter
beginning July 1, 2003, the Interpretation applies also to VIEs created or
variable interests obtained in VIEs before January 31, 2003. The Companys
adoption of the applicable provisions of this Interpretation did not have a
material impact on its financial position or results of operations. The
Company does not expect the adoption of the remaining provisions of this
Interpretation to have a material impact on its financial position or results
of operations.

12.     ADOPTION OF SFAS NO. 142

The Company adopted the provisions of SFAS No. 142 effective January 1, 2002.
As of the adoption date, the Company had unamortized goodwill in the amount of
$189.7 million. In accordance with SFAS No. 142, effective January 1, 2002 the
Company discontinued amortization of goodwill. Goodwill was tested for
impairment by comparing the fair value of goodwill to the carrying value of
goodwill. Fair value was determined using projected operating results and a
combination of analyses which included discounted cash flow calculations,
market multiples and other market information. Key assumptions used in these
estimates include projected operating results, discount rates and peer market
multiples. The implied fair value of goodwill did not support the carrying
value of goodwill primarily due to the Companys highly leveraged capital
structure.

Based upon the results of the Companys initial impairment tests, the Company
recorded an impairment loss of $68.5 million in the quarter ended March 31,
2002, recognized as a cumulative effect of change in accounting principle.
There was no tax effect on the impairment loss due to the fact that the
majority of the related goodwill was non-tax deductible and because of the
Companys federal net operating loss position. The Company is required to
conduct annual impairment tests hereafter, unless specific events arise which
warrant more immediate testing. To date there have been no events warranting
impairment testing since the Company completed its
2002 annual impairment test in September 2002. Any subsequent impairment loss
will be recognized as an operating expense in the Companys consolidated
statements of operations.

22



---



##### Table of Contents



The change in the carrying amount of goodwill for the six months ended June 30,
2003 and 2002 is as follows:

|                                                               |  |                           |             |      |  |   |             |  
|-------------------------------------------------------------- |  | ------------------------- | ----------- | ---- |  | - | ----------- | -
|                                                               |  | Six Months Ended June 30,
|                                                               |  |                          
|                                                               |  | 2003                      |             | 2002
|                                                               |  |                           |             |     
|Goodwill, net of accumulated amortization, beginning of
period |  | $                         | 121,214,000 |      |  | $ | 189,699,000 |  
|Transitional impairment loss                                   |  |                           |            |      |  |   | (68,485,000 | )
|                                                               |  |                           |             |      |  |   |             |  
|Goodwill, net of accumulated amortization, end of period       |  | $                         | 121,214,000 |      |  | $ | 121,214,000 |  
|                                                               |  |                           |             |      |  |   |             |  

13. STOCK BASED COMPENSATION

Prior to the issuance of SFAS No. 148, SFAS No. 123 encouraged, but did not
require, companies to record compensation cost for stock-based employee
compensation plans at fair value. Historically, the Company has chosen to
account for stock option plans using the intrinsic value method as prescribed
in Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to
Employees (APB Opinion No. 25), and related Interpretations. Under APB
Opinion No. 25, no compensation cost related to stock options has been
recognized because all options are issued with exercise prices equal to the
fair market value at the date of grant.

The Company is assessing the three alternative methods of transition for a
voluntary change to the fair value based method of accounting for stock-based
employee compensation included in SFAS No. 148. To date, the Company has
adopted the disclosure provisions of SFAS No. 123. Accordingly, no
compensation cost has been recognized for the option plans. Had compensation
cost for the Companys stock option and employee stock purchase plans been
determined based on the fair value at the grant date of awards for the three
and six months ended June 30, 2003 and 2002 consistent with the provisions of
SFAS No. 123, the Companys net income (loss) and net income (loss) per common
share would have been decreased or increased to the pro forma amounts indicated
below:

|                                                 |         |   |                             |      |                           |   |          |       |      |   |           |      |  |   |             |       |  
|------------------------------------------------ | ------- | - | --------------------------- | ---- | ------------------------- | - | -------- | ----- | ---- | - | --------- | ---- |  | - | ----------- | ----- | -
|                                                 |         |   | Three Months Ended June 30, |      | Six Months Ended June 30,
|                                                 |         |   |                             |      |                          
|                                                 |         |   | 2003                        |      | 2002                      |   | 2003     |       | 2002
|                                                 |         |   |                             |      |                           |   |          |       |     
|Net income (loss)  as reported                  |         | $ | 4,520,000                   |      |                           | $ | (64,000  | )     |      | $ | 8,857,000 |      |  | $ | (66,941,000 | )    
|Additional compensation expense                  |         |   | (4,000                      | )    |                           |   | (69,000  | )     |      |   | (8,000    | )    |  |   | (138,000    | )    
|                                                 |         |   |                             |      |                           |   |          |       |      |   |           |      |  |   |             |      
|Net income (loss)  pro forma                    |         |   | 4,516,000                   |      |                           |   | (133,000 | )     |      |   | 8,849,000 |      |  |   | (67,097,000 | )    
|                                                 |         |   |                             |      |                           |   |          |       |      |   |           |      |  |   |             |      
|Net income (loss) per common
share  as reported |         |   |                             |      |                           |   |          |       |      |   |           |      |  |   |             |      
|                                                 | Basic   |   | $                           | 0.28 |                           |   | $        |      |      |   | $         | 0.54 |  |   | $           | (4.10 | )
|                                                 | Diluted |   | $                           | 0.24 |                           |   | $        |      |      |   | $         | 0.47 |  |   | $           | (3.58 | )
|Net income (loss) per common
share  pro forma   |         |   |                             |      |                           |   |          |       |      |   |           |      |  |   |             |      
|                                                 | Basic   |   | $                           | 0.28 |                           |   | $        | (0.01 | )    |   | $         | 0.54 |  |   | $           | (4.10 | )
|                                                 | Diluted |   | $                           | 0.24 |                           |   | $        | (0.01 | )    |   | $         | 0.47 |  |   | $           | (3.59 | )

23



---



##### Table of Contents



14. SUBSEQUENT EVENTS

On July 1, 2003, the Companys Approved Plan became effective and the Company
successfully emerged from bankruptcy protection. The Approved Plan allows the
Company to continue its business operations uninterrupted, led by its current
management team, and accomplishes the Companys primary goal of restructuring
its long-term debt obligations to its Lenders. In addition, the Approved Plan
provides that the Companys shareholders retain their equity interest in the
Company and that all of the Companys creditors and vendors will be paid 100%
of all amounts they are owed, either immediately or over time with interest.
Pursuant to the Approved Plan, the Companys secured debt to the Lenders is
$250 million and is evidenced by a promissory note in that amount and is
secured by various security agreements. The Company is no longer party to a
credit agreement. The remainder of the amounts due to the Lenders is treated
as unsecured.

The Approved Plan provides that interest is payable monthly on the $250 million
secured debt at a rate of 6.785% per annum. The Approved Plan provides that
interest is payable semiannually (on June 30 and December 31 of each year) on
the Lenders unsecured debt and on the Companys other unsecured debt at a rate
of 8.3675% per annum.

The Approved Plan provides that principal is payable annually on the $250
million secured debt on March 31 of each year, beginning March 31, 2005, in the
amount of one third of the Companys Excess Cash Flow (as defined in the
Approved Plan) for the previous fiscal year. After the unsecured debt of the
Lenders and the general unsecured debt is paid in full, 100% of the Companys
Excess Cash Flow is paid on the $250 million secured debt on such dates. An
estimated prepayment of the Excess Cash Flow Payment is due on September 30,
2004 and on September 30 of each year thereafter, and shall equal one-half of
the amount of the anticipated Excess Cash Flow Payment for the fiscal year.
The maturity date of the $250 million secured debt is July 1, 2009. The
secured debt may be prepaid in whole or in part at any time without penalty.

The Approved Plan provides that principal is payable semi-annually in six equal
installments (on June 30 and December 31 of each year) beginning December 31,
2003 on the Lenders unsecured debt and on the general unsecured debt. In
addition to the scheduled payments referenced above, the holders of the
unsecured debt also receive a payment on March 31, 2004 in the amount of 100%
of the Companys Excess Cash Flow for fiscal year 2003 and payments on March
31, 2005 and March 31, 2006 in the amount of two thirds of the Companys Excess
Cash Flow for the previous fiscal year. The payments from the Companys Excess
Cash Flow are defined as Pro Rata Payments and described in more detail in the
Approved Plan and, if available to be paid, will reduce and be a
credit against any future required semi-annual payments. The Approved Plan is attached hereto as Exhibit 2.1.
Additionally, an estimated prepayment of the Pro Rata Payment is due on
September 30, 2003, September 30, 2004, and September 30, 2005 in an amount
equal to one-half of the anticipated Pro Rata Payment for each fiscal year.
The Company has not yet determined the amount of any estimated prepayment of
the Pro Rata Payment due on September 30, 2003. The Approved Plan also
allows the Company to make prepayments to holders of unsecured debt, either in
whole or in part, at any time without penalty. Any partial prepayments shall
reduce and be a credit against any mandatory payments that are due after the
time of the prepayment.

Prior to emergence from bankruptcy protection, the
Company made adequate protection payments totaling approximately $15.8 million.
The Approved Plan

24



---



##### Table of Contents



provides that the adequate protection payments earn interest at a rate equal to the unsecured debt rate of 8.3675%
per annum until the date on which the adequate protection payment is applied. As of June 30,
2003 interest on the adequate protection payments totaled
$552,000. The adequate protection payments and interest will be applied to the
Lenders unsecured debt and related interest as the scheduled payments and Pro
Rata Payments become due. The maturity date of the unsecured debts is June 30,
2006.

As the reorganization value of the assets of the Debtors immediately before
confirmation date is greater than the total of all post petition liabilities
and allowed claims and the holders of the existing voting shares immediately
before the confirmation received more than 50% of the voting shares of the
Debtors, the Debtors will not apply the provisions of SOP 90-7 for fresh-start
reporting. Upon emergence from bankruptcy protection on July 1, 2003 and prior
to the application of payments made on July 1, 2003, of the total liabilities
subject to compromise of $298,797,000 at June 30, 2003, approximately
$20,806,000 and $277,991,000 will be classified as current and non-current,
respectively.

On July 1, 2003, the Company paid, in full, unsecured claims which individually
totaled $10,000 or less, according to the provisions of the Approved Plan.
Also, on that date, the Company made a partial prepayment to the general
unsecured creditors. The total cash paid on July 1, 2003 to holders of general
unsecured debt was approximately $6.3 million.

The Lenders have filed an appeal of
the Confirmation Order of the Approved Plan.
The Company will contest the appeal and seek to have the Bankruptcy Courts
Confirmation Order affirmed on appeal.

Warrants to purchase 3,265,315 shares of common stock were issued to the
Lenders on June 8, 2001. See Note 2. Under applicable legal principles, the
Company believes that the existing warrants are executory contracts. On July
11, 2003, the Company filed a motion with the Bankruptcy Court seeking approval
to reject these warrants as executory contracts. Several warrant holders
objected to this motion, and a hearing will be scheduled in the
Bankruptcy Court with respect to these issues. If the warrants ultimately are rejected, then the
holders of the rejected warrants may have an unsecured claim against the
Company.

25



---



##### Table of Contents



ITEM 2   MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Quarterly Report on Form 10-Q includes forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995 including,
without limitation, statements containing the words believes, anticipates,
intends, expects, estimates, projects, may, will, likely, could
and words of similar import. Such statements include statements concerning the
Companys Approved Plan (as defined in Note 3 to the interim condensed
consolidated financial statements), other effects and consequences of the
Bankruptcy Filing (as defined in Note 3 to the interim condensed consolidated
financial statements), forecasts upon which the Approved Plan is based,
business strategy, operations, cost savings initiatives, industry, economic
performance, financial condition, liquidity and capital resources, existing
government regulations and changes in, or the failure to comply with,
governmental regulations, legislative proposals for healthcare reform, the
ability to enter into strategic alliances and arrangements with managed care
providers on an acceptable basis, and changes in reimbursement policies. Such
statements are not guarantees of future performance and are subject to various
risks and uncertainties. The Companys actual results may differ materially
from the results discussed in such forward-looking statements because of a
number of factors, including those identified in the Risk Factors section and
elsewhere in this Quarterly Report on Form 10-Q. The forward-looking
statements are made as of the date of this Quarterly Report on Form 10-Q and
the Company does not undertake to update the forward-looking statements or to
update the reasons that actual results could differ from those projected in the
forward-looking statements.

Bankruptcy Filing

On July 31, 2002, American HomePatient, Inc. and 24 of its subsidiaries
(collectively, the Debtors) filed voluntary petitions for relief to
reorganize under Chapter 11 of the U.S. Bankruptcy Code (the Bankruptcy
Filing) in the United States Bankruptcy Court for the Middle District of
Tennessee (the Bankruptcy Court). On July 1, 2003, the Companys plan of
reorganization, which had previously been approved by the Bankruptcy Court (the
Approved Plan), became effective and the Company successfully emerged from
bankruptcy protection. See Note 3 to the interim condensed consolidated
financial statements Proceedings Under Chapter 11 of the Bankruptcy Code,
Note 14 to the interim condensed consolidated financial statements Subsequent
Events, and Managements Discussion and Analysis of Financial Condition and
Results of Operations  Liquidity and Capital Resources.

General

The Company provides home health care services and products to patients through
its 289 centers in 35 states. These services and products are primarily paid
for by Medicare, Medicaid and other third-party payors. The Company has three
principal services or product lines: home respiratory services, home infusion
services and home medical equipment and supplies. Home respiratory services
include oxygen systems, nebulizers, aerosol medications and home ventilators
and are provided primarily to patients with severe and chronic pulmonary
diseases. Home infusion services are used to administer nutrients, antibiotics
and other medications to patients with
medical

26



---



##### Table of Contents



conditions such as neurological impairments, infectious diseases or
cancer. The Company also sells and rents a variety of home medical equipment
and supplies, including wheelchairs, hospital beds and ambulatory aids.

The following table sets forth the percentage of the Companys revenues
represented by each line of business for the periods presented:

|                                            |       |  |                           |     |      |  |    |     |  
|------------------------------------------- | ----- |  | ------------------------- | --- | ---- |  | -- | --- | -
|                                            |       |  | Six Months Ended June 30,
|                                            |       |  |                          
|                                            |       |  | 2003                      |     | 2002
|                                            |       |  |                           |     |     
|Home respiratory therapy services           |       |  | 68                        | %   |      |  | 65 | %  
|Home infusion therapy services              |       |  | 13                        |     |      |  | 15 |    
|Home medical equipment and medical supplies |       |  | 19                        |     |      |  | 20 |    
|                                            |       |  |                           |     |      |  |    |    
|                                            | Total |  |                           | 100 | %    |  |    | 100 | %
|                                            |       |  |                           |     |      |  |    |    

Prior to 1998, the Company had significantly expanded its operations through a
combination of home health care acquisitions and joint ventures and strategic
alliances with integrated health care delivery systems. In 1998, the Company
purposefully slowed its acquisition activity compared to prior years to focus
on existing operations. Since 1998, the Company has not acquired any home
health care businesses or developed any new joint ventures other than
converting several of its previously owned 50% joint ventures to wholly-owned
operations during 1999 and 2000. In March 2002, the Company sold substantially
all of the assets of an infusion center for $1.3 million in cash and used the
proceeds to pay down the Bank Credit Facility.

The Companys strategy for 2003 is to maintain a diversified offering of home
health care services reflective of its current business mix. Respiratory
services will remain a primary focus along with home medical equipment rental
and enteral nutrition products and services.

Government Regulation

General.The Company, as a participant in the health care industry, is
subject to extensive federal, state and local regulation. In addition to the
False Claims Act and other federal and state anti-kickback and self-referral
laws applicable to all of the Companys operations (discussed more fully
below), the operations of the Companys home health care centers are subject to
federal laws covering the repackaging and dispensing of drugs (including
oxygen) and regulating interstate motor-carrier transportation. Such centers
also are subject to state laws (most notably licensing and controlled
substances registration) governing pharmacies, nursing services and certain
types of home health agency activities.

The Companys operations are also subject to a series of laws and regulations
dating back to the Omnibus Budget Reconciliation Act of 1987 (OBRA 1987)
which apply to the Companys operation. Periodic changes have occurred from
time to time since the enactment of OBRA 1987, including reimbursement
reductions and changes to payment rules.

The Federal False Claims Act imposes civil liability on individuals or entities
that submit false or fraudulent claims to the government for payment. False
Claims Act penalties for violations can

27



---



##### Table of Contents



include sanctions, including civil
monetary penalties. As a provider of services under the federal
reimbursement programs such as Medicare, Medicaid and TRICARE (formerly
CHAMPUS), the Company is subject to the anti-kickback statute, also known as
the fraud and abuse law. This law prohibits any bribe, kickback, rebate or
remuneration of any kind in return for, or as an inducement for, the referral
of patients for government-reimbursed health care services. The Company may
also be affected by the federal physician self-referral prohibition, known as
the Stark Law, which, with certain exceptions, prohibits physicians from
referring patients to entities with which they have a financial relationship.
Many states in which the Company operates have adopted similar self-referral
laws, as well as laws that prohibit certain direct or indirect payments or
fee-splitting arrangements between health care providers, under the theory that
such arrangements are designed to induce or to encourage the referral of
patients to a particular provider. In many states, these laws apply to
services reimbursed by all payor sources.

In 1996, the Health Insurance Portability and Accountability Act (HIPAA)
introduced a new category of federal criminal health care fraud offenses. If a
violation of a federal criminal law relates to a health care benefit, then an
individual is guilty of committing a Federal Health Care Offense. The specific
offenses are: health care fraud; theft or embezzlement; false statements,
obstruction of an investigation; and money laundering. These crimes can apply
to claims submitted not only to government reimbursement programs such as
Medicare, Medicaid and TRICARE, but to any third-party payor, and carry
penalties including fines and imprisonment. See Managements Discussion and
Analysis of Financial Condition and Results of Operations  Risk Factors, HIPAA
Compliance for further discussion.

The Company must follow strict requirements with paperwork and billing. As
required by law, it is Company policy that certain service charges (as defined
by Medicare) falling under Medicare Part B are confirmed with a Certificate for
Medical Necessity (CMN) signed by a physician. In January 1999, the Office
of Inspector General of the Department of Health and Human Services (OIG)
published a draft Model Compliance Plan for the Durable Medical Equipment,
Prosthetics, Orthotics and Supply Industry. The OIG has stressed the
importance for all health care providers to have an effective compliance plan.
The Company has created and implemented a compliance program, which it believes
meets the elements of the OIGs Model Plan for the industry. As part of its
compliance program, the Company performs internal audits of the adequacy of
billing documentation. The Companys policy is to voluntarily refund to the
government any reimbursements previously received for claims with insufficient
documentation that are identified in this process and that cannot be corrected.
The Company periodically reviews and updates its policies and procedures in an
effort to comply with applicable laws and regulations; however, certain
proceedings have been and may in the future be commenced against the Company
alleging violations of applicable laws governing the operation of the Companys
business and its billing practices.

The Balanced Budget Act of 1997 introduced several government initiatives which
are either in the planning or implementation stages and which, when fully
implemented, could have a material adverse impact on reimbursement for products
and services provided by the Company. These initiatives include: (i)
Prospective Payment System (PPS) requirements for skilled nursing facilities
and PPS for home health agencies, which do not affect the Company directly but
could affect the Companys contractual relationships with such entities; (ii)
deadlines (as yet undetermined) for obtaining Medicare and Medicaid surety
bonds for home health agencies and DME suppliers; and (iii) pilot projects in
Polk County, Florida and San Antonio, Texas which were

28



---



##### Table of Contents



effective between
October 1, 1999 and September 30, 2002, and February 1, 2001 and
December 31, 2002, respectively, to determine the efficacy of competitive
bidding for certain durable medical equipment (DME), under which Medicare
reimbursements for certain items were reduced between 3.6% to 34% from the then
current Medicare fee schedules (the Company participated to some extent in both
pilot projects). At expiration, the DME items reverted to normal Medicare fees
and procedures, although the Bush administration has announced that it intends
to expand competitive bidding on a national basis, building on these two pilot
projects that yielded savings to Medicare. The United States House of
Representatives recently passed a bill that includes provisions for a national
competitive bidding program for durable medical equipment, including home
oxygen equipment. The United States Senate recently passed a bill that
includes provisions for a seven year freeze in the consumer price index (CPI)
update for durable medical equipment and off-the-shelf orthotics. The Company
cannot predict at this time the outcome of proposed legislation related to a
national competitive bidding program or the financial impact of such a program
on the Companys business, if it should become law.

In April 2003, the OIG issued a special advisory bulletin addressing certain
contractual arrangements that would not be included in a safe harbor as
defined under the federal anti-kickback statutes. This bulletin specifically
focuses on contractual arrangements where a health care provider in one line of
business expands into a related health care business by contracting with an
existing provider of a related item or service. The Company is a party to
several contracts that could potentially be impacted by this special advisory
bulletin. Management is in the process of assessing its compliance with the
provisions of this bulletin and has not determined the financial impact, if
any, of complying with these provisions.

The Company is also subject to state laws governing Medicaid, professional
training, licensure, financial relationships with physicians and the dispensing
and storage of pharmaceuticals. The facilities operated by the Company must
comply with all applicable laws, regulations and licensing standards and many
of the Companys employees must maintain licenses to provide some of the
services offered by the Company. Additionally, certain of the Companys
employees are subject to state laws and regulations governing the professional
practice of respiratory therapy, pharmacy and nursing.

Information about individuals and other health care providers who have been
sanctioned or excluded from participation in government reimbursement programs
is readily available on the Internet, and all health care providers, including
the Company, are held responsible for carefully screening entities and
individuals they employ or do business with, to avoid contracting with an
excluded provider. The entity cannot bill government programs for services or
supplies provided by an excluded provider, and the federal government may also
impose sanctions, including financial penalties, on companies that contract
with excluded providers.

Health care law is an area of extensive and dynamic regulatory oversight.
Changes in laws or regulations or new interpretations of existing laws or
regulations can have a dramatic effect on permissible activities, the relative
costs associated with doing business, and the amount and availability of
reimbursement from government and other third-party payors. There can be no
assurance that federal, state or local governments will not impose additional
standards or change existing standards or interpretations.

29



---



##### Table of Contents



Enforcement Activities.In recent years, various state and federal
regulatory agencies have stepped up investigative and enforcement activities
with respect to the health care industry, and
many health care providers, including the Company and other durable
medical equipment suppliers, have received subpoenas and other requests for
information in connection with their business operations and practices. From
time to time, the Company also receives notices and subpoenas from various
government agencies concerning plans to audit the Company, or requesting
information regarding certain aspects of the Companys business. The Company
cooperates with the various agencies in responding to such subpoenas and
requests. The Company expects to incur additional legal expenses in the future
in connection with existing and future investigations.

The government has broad authority and discretion in enforcing applicable laws
and regulations; therefore, the scope and outcome of any such investigations,
inquiries, or legal actions cannot be predicted. There can be no assurance
that federal, state or local governments will not impose additional regulations
upon the Companys current activities nor that the Companys past activities
will not be found to have violated some of the governing laws and regulations.
Any such regulatory changes or findings of violations of laws could adversely
affect the Companys business and financial position, and could even result in
the exclusion of the Company from participating in Medicare, Medicaid, and
other government reimbursement programs.

Legal Proceedings.On June 11, 2001, a settlement agreement (the
Government Settlement) was entered among the Company, the United States of
America, acting through the United States Department of Justice (DOJ) and on
behalf of the OIG and the TRICARE Management Activity, and a former Company
employee, as relator. The Government Settlement was approved by the United
States District Court for the Western District of Kentucky, the court in which
the relators false claim action was filed. The Government Settlement covers
alleged improprieties by the Company during the period from January 1, 1995
through December 31, 1998, including allegedly improper billing activities and
allegedly improper remuneration to and contracts with physicians, hospitals and
other healthcare providers. Pursuant to the Government Settlement, the Company
made an initial payment of $3,000,000 in the second quarter of 2001 and agreed
to make additional payments in the principal amount of $4,000,000, together
with interest on this amount, in installments due at various times until March
2006. The Company also paid the relators attorneys fees and expenses.
Pursuant to the Approved Plan, the amounts owed pursuant to the Government
Settlement will be paid in full in accordance with the Government Settlement.
The Company has reserved $4,337,000 for its future obligations pursuant to the
Government Settlement.

Other Claims and Litigation.Other than the Government Settlement, all
other claims and litigation described below are disputed by the Company. To
the extent the Bankruptcy Court ultimately determines that any of the parties
has a valid claim pursuant to the Approved Plan, such claim will be paid as a
general unsecured claim.

The relator in the false claim action giving rise to the Government Settlement
also asserted in his amended complaint that the Company discriminated against
him because of his reports of alleged wrong-doing to the government. The
relator filed a claim in the Companys bankruptcy proceeding. The Company has
objected to that claim.

The Company also was named as a defendant in two other False Claims Act cases
filed prior to the Companys bankruptcy. In each of those cases, the DOJ
declined to intervene and both cases were

30



---



##### Table of Contents



subsequently dismissed in March 2001.
The first of these cases, United States ex rel. Kirk S.
Corsello v. Lincare, et al. (N.D. Ga.), was dismissed with prejudice on motion
of the Company on March 9, 2001. The appeal of that dismissal was argued in
November 2001; however, in December 2001 the Court of Appeals for the Eleventh
Circuit dismissed the appeal on jurisdictional grounds and returned the case to
the trial court. In January 2002, one of the other defendants filed a Motion
for Reconsideration with the Court of Appeals, and the Court of Appeals denied
the motion on July 10, 2002. On August 5, 2002 the Company filed a Notice of
Bankruptcy which stayed the proceedings as to the Company. The other case,
United States ex rel. Alan D. Hutchison v. Respironics, et al. (S.D. NY and
N.D. Ga.), was dismissed without prejudice on Mr. Hutchisons own motion on
March 22, 2001. Mr. Hutchisons qui tam complaint alleged that the Company and
numerous other unrelated defendants filed false claims with Medicare for
ventilators that the defendants allegedly knew were not medically necessary.
To the Companys knowledge, neither Corsello or Hutchison filed a claim in the
Companys bankruptcy.

Prior to the Companys Bankruptcy Filing, the Company was informed that the
United States was investigating its conduct during periods after December 31,
1998, and the Company believes that this investigation was prompted by another
qui tam complaint against the Company under the False Claims Act. The Company
has not seen a complaint in this action and, to the Companys knowledge, no
claim was filed against the Company by the United States or any party
purporting to act on its behalf for any amounts other than those owed pursuant
to the Government Settlement.

There can be no assurances as to the final outcome of any pending False Claims
Act lawsuits. Possible outcomes include, among other things, the repayment of
reimbursements previously received by the Company related to billed claims that
are found to be improper, the imposition of fines or penalties, and the
suspension or exclusion of the Company from participation in the Medicare,
Medicaid and other government reimbursement programs. Other than the
$4,337,000 reserve discussed above which relates to the Government Settlement,
the Company has not recorded any reserves related to the unsettled government
investigations. The outcome of any pending lawsuits or future settlements
could have a material adverse effect on the Company.

Medicare Reimbursement for Oxygen Therapy Services

The Medicare reimbursement rate for oxygen related services was reduced by 25%
beginning January 1, 1998 as a result of the Balanced Budget Act of 1997 with
an additional reduction of 5% beginning January 1, 1999. The reimbursement
rate for certain drugs and biologicals covered under Medicare was also reduced
by 5% beginning January 1, 1998. The Company is one of the nations largest
providers of home oxygen services to patients, many of whom are Medicare
recipients, and is therefore significantly affected by this legislation.
Medicare oxygen reimbursements account for a significant part of the Companys
on-going revenues. In January 2001, federal legislation was signed into law
that provided for a one-time increase, beginning July 1, 2001, in Medicare
reimbursement rates for home medical equipment, excluding oxygen related
services, based on the consumer price index (CPI). There have been no
significant increases since this law was passed. Medicare also has the option
of developing fee schedules for PEN and home dialysis supplies and equipment,
although currently there is no timetable for the development or implementation
of such fee schedules. Following promulgation of a final rule, effective
February 11, 2003, CMS also has inherent reasonableness authority to modify
payment rates for all Medicare Part B items and services by as much as 15% per
year without industry
consultation, publication or public comment, if the rates are determined to be
grossly excessive or grossly deficient. Therefore, the Company

31



---



##### Table of Contents



cannot be
certain that additional reimbursement reductions for oxygen therapy services or
other services and products provided by the Company will not occur. See
Managements Discussion and Analysis of Financial Condition and Results of
Operations  Significant Accounting Policies and Managements Discussion and
Analysis of Financial Condition and Results of Operations  Government
Regulation.

Critical Accounting Policies

Managements Discussion and Analysis of Financial Condition and Results of
Operations are based upon the Companys consolidated financial statements. The
preparation of these consolidated financial statements in accordance with
accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and the disclosure of contingent assets and
liabilities at the dates of the financial statements, and the reported amounts
of revenues and expenses during the reporting periods. On an on-going basis,
management evaluates its critical accounting policies and estimates. See Note
11 to the interim condensed consolidated financial statements Recent
Accounting Pronouncements.

A critical accounting policy is one which is both important to the
understanding of the financial condition and results of operations of the
Company and requires managements most difficult, subjective or complex
judgments, often as a result of the need to make estimates about the effect of
matters that are inherently uncertain. Management believes the following
accounting policies fit this definition:

Revenue Recognition and Allowance for Doubtful Accounts.The Company
provides credit for a substantial part of its non third-party reimbursed
revenues and continually monitors the credit-worthiness and collectibility of
amounts due from its patients. Approximately 61% of the Companys year to date
2003 revenues are derived from participation in Medicare and state Medicaid
programs. Amounts paid under these programs are generally based upon a fixed
rate. Revenues are recorded at the expected reimbursement rates when the
services are provided, merchandise delivered or equipment rented to patients.
Although amounts earned under the Medicare and Medicaid programs are subject to
review by such third-party payors, subsequent adjustments to reimbursements as
a result of such reviews are historically insignificant as these reimbursements
are based on fixed fee schedules. In the opinion of management, adequate
provision has been made for any adjustment that may result from such reviews.
Any differences between estimated settlements and final determinations are
reflected in operations in the year finalized.

Sales and related services revenues include all product sales to patients and
are derived from the provision of infusion therapies, the sale of home health
care equipment and supplies, the sale of aerosol medications and respiratory
therapy equipment and supplies, and services related to the delivery of these
products. Sales revenues are recognized at the time of delivery and are billed
using fixed fee schedules based upon the type of product and the payor.
Rentals and other patient revenues are derived from the rental of home health
care equipment, enteral pumps and equipment related to the provision of
respiratory therapy. All rentals of equipment are provided by the Company on a
month-to-month basis and are billed using fixed monthly fee schedules based
upon
the type of rental and the payor. The fixed monthly fee encompasses the rental
of the product as well as the delivery and the set-up and instruction by the
product technician.

32



---



##### Table of Contents



The Company recognizes revenues at the time services are performed. As such, a
portion of patient receivables consists of unbilled receivables for which the
Company has not obtained all of the necessary medical documentation, but has
provided the service or equipment. The Company calculates its allowance for
doubtful accounts based upon the type of receivable (billed or unbilled) as
well as the age of the receivable. As a receivable balance ages, an
increasingly larger allowance is recorded for the receivable. All billed
receivables over one year old and all unbilled receivables over 180 days old
are fully reserved. Management believes that the recorded allowance for
doubtful accounts is adequate and that historical collections substantiate the
percentages at which amounts are reserved. However, the Company is subject to
loss to the extent uncollectible receivables exceed its allowance for doubtful
accounts. If the Company were to experience a deterioration in the aging of
its accounts receivable due to disruptions or a slow down in cash collections,
the Companys allowance for doubtful accounts and bad debt expense would likely
increase from current levels. Conversely, an improvement in the Companys cash
collection trends and in its receivable aging would likely result in a decrease
in both the allowance for doubtful accounts and bad debt expense.

Inventory Valuation Reserves and Cost of Sales Recognition. Inventories
represent goods and supplies and are priced at the lower of cost (on a
first-in, first-out basis) or market value. The Company recognizes cost of
sales and relieves inventory at estimated amounts on an interim basis based
upon the type of product sold and payor mix, and performs physical counts of
inventory at each center on an annual basis. Any resulting adjustment from
these physical counts is charged to cost of sales. A reserve established by
management for the valuation of inventory consisting of reserves for incorrect
cost of sales percentage estimates, inaccurate counts, obsolete and slow moving
items and reserves for specific inventory. The reserves are based on a
percentage of gross sales, a percentage of inventory or an amount for
specifically identified inventory items. Management believes the current
reserve is adequate to absorb estimated reductions in the account balance. The
Company is subject to loss for unrecorded inventory adjustments in excess of
its recorded inventory reserves.

Rental Equipment Reserves. Rental equipment is rented to patients for use
in their homes and is depreciated over the equipments estimated useful life.
On an annual basis, the Company performs physical counts of rental equipment at
each center and reconciles all recorded rental assets to internal billing
reports. Any resulting adjustment for unlocated or obsolete equipment is
charged to rental equipment depreciation expense. Since rental equipment is
maintained in the patients home, the Company is subject to loss resulting from
lost equipment as well as losses for outdated or obsolete equipment.
Management records a reserve for potentially lost, broken, or obsolete rental
equipment based upon historical adjustment amounts and believes the recorded
rental reserve is adequate. The Company is subject to loss for unrecorded
adjustments in excess of its recorded rental equipment reserves.

Valuation of Long-lived Assets. In accordance with Statement of Financial
Accounting Standards No. 144, Accounting for the Impairment or Disposal of
Long-Lived Assets (SFAS No. 144), management evaluates long-lived assets for
impairment whenever events or changes in circumstances indicate that the
carrying value of an asset may not be recoverable. Management utilizes
estimated undiscounted future cash flows to determine if an impairment exists.
When this
analysis indicates an impairment exists, the amount of loss is determined
based upon a comparison of estimated fair value with the carrying value of the
asset. While

33



---



##### Table of Contents



management believes that the estimates of future cash flows are
reasonable, different assumptions regarding such cash flows could materially
affect the evaluations.

Valuation of Goodwill and Other Intangible Assets.Goodwill represents
the excess of cost over the fair value of net assets acquired. In June 2001,
the Financial Accounting Standards Board (FASB) issued Statement of Financial
Accounting Standards No. 142, Goodwill and Other Intangible Assets (SFAS No.
142). The Company was required to adopt the provisions of this statement
effective January 1, 2002. SFAS No. 142 requires that intangible assets with
finite useful lives be amortized and that goodwill and intangible assets with
indefinite lives no longer be amortized. Instead, goodwill and intangible
assets with indefinite lives are required to be tested for impairment on an
annual basis and when an event occurs or circumstances change such that it is
reasonably possible that an impairment may exist. The Company selected
September 30 as its annual testing date.

Upon adoption of SFAS No. 142, goodwill was tested for impairment by comparing
the fair value of goodwill to the carrying value of goodwill. The fair value
was determined using a combination of analyses which included discounted cash
flow calculations, market multiples and other market information. Key
assumptions used in these estimates include projected operating results,
discount rates and peer market multiples. The implied fair value of goodwill
did not support the carrying value of goodwill primarily due to the Companys
highly leveraged capital structure, which resulted in impairment of $68.5
million. This impairment charge was recorded as a cumulative effect of change
in accounting principle in the first quarter of 2002. There was no tax effect
on the impairment loss due to the fact that the majority of the related
goodwill was non-tax deductible and because of the Companys federal net
operating loss position.

Self Insurance.Self-insurance reserves primarily represent the accrual
for self-insurance or large deductible risks associated with employee health
insurance and workers compensation insurance. The Company is insured for
workers compensation but retains the first $250,000 of each claim. The
Company is not maintaining annual aggregate stop loss coverage for 2003 and did
not maintain annual aggregate stop loss coverage for 2002, as such coverage was
not available. Judgments used in determining the reserves related to workers
compensation include loss development factors, frequency of claims and severity
of claims. The estimated liability for workers compensation claims totaled
approximately $3.6 million and $3.3 million as of June 30, 2003 and December
31, 2002, respectively. The Company utilizes analyses prepared by its
third-party administrator based on historical claims information to support the
required reserve and related expense associated with workers compensation.
The Company records claims expense by plan year based on the lesser of the
aggregate stop loss (if applicable) or the developed losses as calculated by
its third-party administrator.

The Company is also self-insured for health insurance for substantially all
employees for the first $150,000 on a per person, per year basis and maintains
annual aggregate stop loss coverage. The health insurance policies are limited
to maximum lifetime reimbursements of $2.0 million per person for 2003 and
2002. The estimated liability for health insurance claims totaled
approximately $1.7 million and $1.8 million as of June 30, 2003 and December
31, 2002, respectively. The Company reviews health insurance trends and
payment history and maintains a reserve for incurred but not reported claims
based upon its assessment of lag time in reporting and
paying claims. Judgments include assessing historical paid claims, average
lags between the

34



---



##### Table of Contents



claims incurred dates, reported dates and paid dates, the
frequency of claims and the severity of claims.

The Company is required to maintain cash collateral accounts with the insurance
companies related to its self-insurance obligations. The Company currently
maintains cash collateral balances of $4.7 million.

Management continually analyzes its reserves for incurred but not reported
claims related to its self-insurance programs and believes these reserves to be
adequate. However, significant judgment is involved in assessing these
reserves, and the Company is at risk for differences between actual settlement
amounts and recorded reserves, and any resulting adjustments are included in
expense once a probable amount is known.

Results of Operations

The Company reports its revenues as follows: (i) sales and related services
and (ii) rentals and other revenues. Sales and related services revenues are
derived from the provision of infusion therapies, the sale of home health care
equipment and supplies, the sale of aerosol and respiratory therapy equipment
and supplies and services related to the delivery of these products. Rentals
and other revenues are derived from the rental of home health care equipment,
enteral pumps and equipment related to the provision of respiratory therapies.
Cost of sales and related services includes the cost of equipment, drugs and
related supplies sold to patients. Cost of rentals and other revenues includes
the costs of oxygen and rental supplies, demurrage for leased oxygen tanks,
rent expense for leased equipment, and rental equipment depreciation expense,
and excludes delivery expenses and salaries associated with the rental set-up.
Operating expenses include operating center labor costs, delivery expenses,
division and area management expenses, selling costs, occupancy costs, billing
center costs, provision for doubtful accounts, and other operating costs.
General and administrative expenses include corporate and senior management
expenses.

The majority of the Companys hospital joint ventures are not consolidated for
financial statement reporting purposes. Earnings from hospital joint ventures
represent the Companys equity in earnings from unconsolidated hospital joint
ventures and management and administrative fees from unconsolidated hospital
joint ventures.

Sale of Assets of Center.In the quarter ended March 31, 2002, the
Company recorded a pre-tax gain of $0.7 million related to the sale of the
assets of an infusion business and nursing agency (collectively, the Center).
Effective March 19, 2002, substantially all of the assets of the Center were
sold for approximately $1.3 million in cash. During the six months ended June
30, 2002 the Center generated approximately $1.9 million in total revenues.
The proceeds of the sale were used to pay down debt under the Companys Bank
Credit Facility.

Cumulative Effect of Change in Accounting Principle.The Company adopted
the provisions of SFAS No. 142 effective January 1, 2002. As of the adoption
date, the Company had unamortized goodwill in the amount of $189.7 million. In
accordance with SFAS No. 142, effective January 1, 2002 the Company
discontinued amortization of goodwill. Goodwill was tested for impairment by
comparing the fair value of goodwill to the carrying value of goodwill.
Fair value was determined using a combination of analyses which included
discounted cash flow

35



---



##### Table of Contents



calculations, market multiples and other market
information. The implied fair value of goodwill did not support the carrying
value of goodwill.

Based upon the results of the Companys initial impairment tests, the Company
recorded an impairment loss of $68.5 million, with no related tax effect, in
the quarter ended March 31, 2002, recognized as a cumulative effect of change
in accounting principle. There was no tax effect on the impairment loss due to
the fact that the majority of the related goodwill was non-tax deductible and
because of the Companys federal net operating loss position. The Company
conducts annual impairment tests on September 30 of each year unless specific
events arise which warrant more immediate testing. Any subsequent impairment
losses will be recognized as an operating expense in the Companys consolidated
statements of operations.

Reorganization Items.The Company has incurred reorganization expenses as
a result of reorganization under Chapter 11 of the Federal Bankruptcy Code. In
accordance with the American Institute of Certified Public Accountants
Statement of Position 90-7, Financial Reporting by Entities in Reorganization
Under the Bankruptcy Code (SOP 90-7), all revenues, expenses, realized gains
and losses, and provisions for losses and expenses resulting from the
reorganization are reported separately as Reorganization Items. These items
include, but are not limited to, professional fees and other expenses incurred
related to the Chapter 11 proceedings, write-off of deferred financing costs,
and provision for damages from future lease rejections.

36



---



##### Table of Contents



The following table and discussion sets forth items from the Companys
consolidated statements of operations as a percentage of revenues for the
periods indicated:

|                                                                                                                                |                   |  |                        |      |                  |  |       |      |      |  |       |      |   |  |       |       |   
|------------------------------------------------------------------------------------------------------------------------------- | ----------------- |  | ---------------------- | ---- | ---------------- |  | ----- | ---- | ---- |  | ----- | ---- | - |  | ----- | ----- | --
|                                                                                                                                |                   |  | Percentage of Revenues
|                                                                                                                                |                   |  |                       
|                                                                                                                                |                   |  | Three Months Ended     |      | Six Months Ended
|                                                                                                                                |                   |  | June 30,               |      | June 30,        
|                                                                                                                                |                   |  |                        |      |                 
|                                                                                                                                |                   |  | 2003                   |      | 2002             |  | 2003  |      | 2002
|                                                                                                                                |                   |  |                        |      |                  |  |       |      |     
|Revenues                                                                                                                        |                   |  | 100.0                  | %    |                  |  | 100.0 | %    |      |  | 100.0 | %    |   |  | 100.0 | %    
|Cost of sales and related services                                                                                              |                   |  | 21.1                   |      |                  |  | 19.7  |      |      |  | 21.0  |      |   |  | 20.2  |      
|Cost of rentals and other
revenues, including rental
equipment depreciation expense                                             |                   |  | 10.8                   |      |                  |  | 10.8  |      |      |  | 10.5  |      |   |  | 10.6  |      
|Operating expenses, including bad
debt expense                                                                                  |                   |  | 55.5                   |      |                  |  | 56.7  |      |      |  | 56.4  |      |   |  | 57.4  |      
|General and administrative                                                                                                      |                   |  | 5.0                    |      |                  |  | 5.1   |      |      |  | 5.2   |      |   |  | 5.2   |      
|Earnings from joint ventures                                                                                                    |                   |  | (1.4                   | )    |                  |  | (1.4  | )    |      |  | (1.5  | )    |   |  | (1.5  | )    
|Depreciation, excluding rental
equipment, and amortization
expense                                                              |                   |  | 1.0                    |      |                  |  | 1.4   |      |      |  | 1.1   |      |   |  | 1.3   |      
|Amortization of deferred
financing costs                                                                                        |                   |  |                       |      |                  |  | 0.9   |      |      |  |      |      |   |  | 1.0   |      
|Interest expense                                                                                                                |                   |  |                       |      |                  |  | 6.4   |      |      |  |      |      |   |  | 6.4   |      
|Other (income) expense, net                                                                                                     |                   |  |                       |      |                  |  | (0.1  | )    |      |  | 0.1   |      |   |  | (0.1  | )    
|Gain on sale of assets of center                                                                                                |                   |  |                       |      |                  |  |      |      |      |  |      |      |   |  | (0.4  | )    
|Chapter 11 financial advisory
expenses incurred prior to filing
bankruptcy                                                      |                   |  |                       |      |                  |  | 0.4   |      |      |  |      |      |   |  | 0.2   |      
|                                                                                                                                |                   |  |                        |      |                  |  |       |      |      |  |       |      |   |  |       |      
|                                                                                                                                | Total expenses    |  |                        | 92.0 |                  |  |       | 99.9 |      |  |       | 92.8 |   |  |       | 100.3 |   
|                                                                                                                                |                   |  |                        |      |                  |  |       |      |      |  |       |      |   |  |       |      
|Income (loss) from operations
before reorganization items,
income taxes and cumulative
effect of change in accounting
principle |                   |  | 8.0                    |      |                  |  | 0.1   |      |      |  | 7.2   |      |   |  | (0.3  | )    
|Reorganization items                                                                                                            |                   |  | 2.4                    |      |                  |  |      |      |      |  | 1.7   |      |   |  |      |      
|Provision for (benefit from)
income taxes                                                                                       |                   |  | 0.1                    |      |                  |  | 0.1   |      |      |  | 0.1   |      |   |  | (1.2  | )    
|Cumulative effect of change in
accounting principle                                                                             |                   |  |                       |      |                  |  |      |      |      |  |      |      |   |  | (43.1 | )    
|                                                                                                                                |                   |  |                        |      |                  |  |       |      |      |  |       |      |   |  |       |      
|                                                                                                                                | Net income (loss) |  |                        | 5.5  | %                |  |       |     | %    |  |       | 5.4  | % |  |       | (42.2 | )%
|                                                                                                                                |                   |  |                        |      |                  |  |       |      |      |  |       |      |   |  |       |      

37



---



##### Table of Contents



Three Months Ended June 30, 2003 Compared to Three Months Ended June 30, 2002

Revenues.Revenues increased from $79.1 million for the quarter ended June 30,
2002 to $82.9 million for the same period in 2003, an increase of $3.8 million,
or 4.8%. The increase in revenues is a result of the Companys sales and
marketing efforts. Following is a discussion of the components of revenues:



| |                                                                                                                                                                                                                             
| | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | Sales and Related Services Revenues.Sales and related services revenues
increased from $33.8 million for the quarter ended June 30, 2002 to $36.2
million for the same period of 2003, an increase of $2.4 million, or
7.1%.
|
| | Rentals and Other Revenues. Rentals and other revenues increased from
$45.3 million for the quarter ended June 30, 2002 to $46.7 million for
the same period in 2003, an increase of $1.4 million, or 3.1%.                 

Cost of Sales and Related Services. Cost of sales and related services
increased from $15.6 million for the quarter ended June 30, 2002 to $17.4
million for the same period in 2003, an increase of $1.8 million, or 11.5%. As
a percentage of sales and related services revenues, cost of sales and related
services increased from 46.1% for the quarter ended June 30, 2002 to 48.2% for
the same period in 2003. This increase is primarily attributable to a greater
level of rental equipment items converted to sales transactions in the current
year period. A rental that is converted to a sale typically has a high cost of
sales component on the sale portion of the transaction due to the limited sales
proceeds paid by the payor.

Cost of Rentals and Other Revenues. Cost of rentals and other revenues
increased from $8.6 million for the quarter ended June 30, 2002 to $9.0 million
for the same period in 2003, an increase of $0.4 million, or 3.5%. As a
percentage of rentals and other revenue, cost of rentals and other revenues
increased from 18.9% for the quarter ended June 30, 2002 to 19.2% for the same
period in 2003. This increase is primarily attributable to a higher level of
rental equipment depreciation. The Company has purchased additional rental
equipment to meet the growth in its equipment rentals and to meet the needs of
a growing patient base.

Operating Expenses. Operating expenses increased from $44.9 million for the
quarter ended June 30, 2002 to $46.0 million for the same period in 2003, an
increase of $1.1 million, or 2.4%. This increase is primarily the result of
higher personnel-related expenses in the current year quarter associated with
the hiring of additional account executives during the latter half of 2002 and
increased insurance expenses, offset by a $0.5 million reduction in bad debt
expense. Bad debt expense was 3.4% of revenues for the quarter ended June 30,
2002 compared to 2.7% for the same quarter of 2003. The decrease primarily is
the result of operational improvements and processing efficiencies at the
Companys billing centers. As a percentage of revenues, operating expenses
decreased from 56.7% to 55.5% for the quarters ended June 30, 2002 and 2003,
respectively.

General and Administrative Expenses. General and administrative expenses
remained unchanged at $4.1 million for the quarters ended June 30, 2002 and
June 30, 2003. As a percentage of revenues, general and administrative
expenses were 5.0% and 5.1% for the quarters ended June 30, 2003 and 2002,
respectively.

38



---



##### Table of Contents



Earnings from Hospital Joint Ventures. Earnings from hospital joint ventures
increased slightly from $1.1 million for the quarter ended June 30, 2002 to
$1.2 million for the quarter ended June 30, 2003.

Depreciation and Amortization. Depreciation (excluding rental equipment) and
amortization expenses decreased from $1.1 million for the quarter ended June
30, 2002 to $0.9 million for the same period in 2003, a decrease of $0.2
million, or 18.2%. This decrease primarily is attributable to certain property
and equipment becoming fully depreciated.

Amortization of Deferred Financing Costs. There was no amortization of
deferred financing costs in the quarter ended June 30, 2003 compared to $0.7
million in the same quarter of 2002. This primarily is attributable to the
cessation of finance cost amortization and the accelerated write-off of
deferred financing costs to reorganization items as of July 31, 2002 as a
result of the Bankruptcy Filing on July 31, 2002.

Interest Expense (Income), Net. Interest expense (income), net changed from
$5.1 million for the quarter ended June 30, 2002 to $0.1 million for the same
period in 2003. This change is attributable to the Company ceasing to record
interest expense as well as the annual fee associated with the Amended Credit
Agreement as a result of the Bankruptcy Filing on July 31, 2002. Post-petition
interest excluded from the statements of operations for the three months ended
June 30, 2003, of $6.2 million, represents the default rate of interest
pursuant to the terms described in the Amended Credit Agreement.

Other (Income) Expense, Net. Other (income) expense, net primarily relates to
investment losses or gains associated with split dollar life insurance
policies. Income of $0.1 million was recorded in the quarter ended June 30,
2002.

Provision for Income Taxes. The provision for income taxes remained unchanged
at $100,000 for the quarters ended June 30, 2002 and June 30, 2003.

Six Months Ended June 30, 2003 Compared to Six Months Ended June 30, 2002

The results of operations between 2002 and 2003 are impacted by the asset sale
of an infusion center in the first quarter of 2002.

Revenues.Revenues increased from $158.9 million for the six months ended June
30, 2002 to $165.4 million for the same period in 2003, an increase of $6.5
million, or 4.1%. In March of 2002, the Company sold substantially all of the
assets of an infusion center, which contributed $1.9 million in revenue during
the first quarter of 2002. Excluding the revenues of the sold center in the
first quarter of 2002, same-location revenues for the six months of 2003
increased $8.4 million, or 5.4%. The increase in revenues is attributable to
the Companys sales and marketing efforts. Following is a discussion of the
components of revenues:



| |                                                                                                                                                                                                                                                                                                                                                                                                                                                              
| | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | Sales and Related Services Revenues. Sales and related services revenues
increased from $68.6 million for the six months ended June 30, 2002 to
$72.6 million for the same period in 2003, an increase of $4.0 million,
or 5.8%. Excluding $1.9 million of sales and related
services revenues of the sold center in the first quarter of 2002,
same-location sales and related services revenues for the six months of
2003 increased $5.9 million, or 8.8%.

39



---



##### Table of Contents





| |                                                                                                                                                                                                               
| | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | Rentals and Other Revenues. Rentals and other revenues increased from
$90.3 million for the six months ended June 30, 2002 to $92.8 million for
the same period in 2003, an increase of $2.5 million, or 2.8%.

Cost of Sales and Related Services. Cost of sales and related services
increased from $32.1 million for the six months ended June 30, 2002 to $34.7
million for the same period in 2003, an increase of $2.6 million, or 8.1%. As
a percentage of sales and related services revenues, cost of sales and related
services increased from 46.8% for the six months ended June 30, 2002 to 47.9%
for the same period in 2003. This increase is primarily attributable to a
greater level of rental equipment items converted to sales transactions in the
current year period. A rental that is converted to a sale typically has a high
cost of sales component on the sale portion of the transaction due to the
limited sales proceeds paid by the payor.

Cost of Rentals and Other Revenues.Cost of rentals and other revenues
increased from $16.8 million for the six months ended June 30, 2002 to $17.4
million for the same period in 2003, an increase of $0.6 million, or 3.6%. As
a percentage of rentals and other revenue, cost of rentals and other revenues
were 18.6% and 18.8% for the six months ended June 30, 2002 and 2003,
respectively. This increase is primarily attributable to a higher level of
rental equipment depreciation. The Company has purchased additional rental
equipment to meet the growth in its equipment rentals and to meet the needs of
a growing patient base.

Operating Expenses. Operating expenses increased from $91.2 million for the
six months ended June 30, 2002 to $93.3 million for the same period in 2003, an
increase of $2.1 million, or 2.3%. Bad debt expense was 4.3% of revenue for
the six months ended June 30, 2002 compared to 3.2% of revenue for the same
period in 2003. The decrease primarily is the result of operational
improvements and processing efficiencies at the Companys billing centers.

General and Administrative Expenses. General and administrative expenses
increased from $8.3 million for the six months ended June 30, 2002 to $8.7
million for the same period in 2003, an increase of $0.4 million, or 4.8%. As
a percentage of revenues, general and administrative expenses were 5.2% for the
six months ended June 30, 2002 and 2003.

Earnings from Hospital Joint Ventures.Earnings from hospital joint ventures
remained unchanged at $2.4 million for the six months ended June 30, 2002 and
2003.

Depreciation and Amortization. Depreciation (excluding rental equipment) and
amortization expenses decreased from $2.1 million for the six months ended June
30, 2002 to $1.8 million for the same period in 2003, a decrease of $0.3
million, or 14.3%. This remaining decrease is primarily attributable to
certain property and equipment becoming fully depreciated.

Amortization of Deferred Financing Costs.There was no amortization of
deferred financing costs for the six months ended June 30, 2003 compared to
$1.5 million in the same period of 2002. This primarily is attributable to the
cessation of finance cost amortization and the accelerated write-off of
deferred financing costs to reorganization items as of July 31, 2002 as a
result of the Bankruptcy Filing on July 31, 2002.

40



---



##### Table of Contents



Other (Income) Expense, Net.Other (income) expense, net primarily relates to
investment losses or gains associated with collateral interest with split
dollar life insurance policies. Other income was $0.2 million for the six
month period ended June 30, 2002 compared to $0.1 million of other expense for
the same period in 2003.

Gain on Sales of Assets of Centers.In the first quarter of 2002, the Company
recorded a gain of $0.7 million on the sale of the assets of an infusion
business and nursing agency.

Interest Expense (Income), Net. Interest expense (income), net changed from
$10.2 million for the quarter ended June 30, 2002 to $(0.1) million for the
same period in 2003. This change is attributable to the Company ceasing to
record interest expense as a result of the Bankruptcy Filing on July 31, 2002.
Post-petition interest excluded from the statements of operations for the six
months ended June 30, 2003, of $12.5 million, represents the default rate of
interest pursuant to the terms described in the Amended Credit Agreement.

Chapter 11 Financial Advisory Expenses Incurred Prior to Filing Bankruptcy.In
the six months ended June 30, 2002 the Company incurred $314,000 related to
financial advisory and legal services in preparation of a possible Chapter 11
filing due to the Companys December 2002 debt maturity.

Provision for (Benefit from) Income Taxes.The provision for (benefit from)
income taxes was $(1.9) million for the six months ended June 30, 2002 compared
to $0.2 million for the six months ended June 30, 2003. The benefit recorded
in 2002 was the result of the enactment of the Job Creation and Workers
Assistance Act of 2002.

History of Indebtedness to Lenders

Overview.The Company is indebted to a syndicate of lenders (the
Lenders), with Bank of Montreal serving as agent for the Lenders. The
indebtedness arose out of a credit agreement entitled the Fifth Amended and
Restated Credit Agreement (the Amended Credit Agreement), which Amended
Credit Agreement was entered into as of June 8, 2001. The indebtedness owed to
the Lenders as of July 31, 2002, the date of the Companys Bankruptcy Filing
(as defined in Note 3), totaled approximately $278.7 million. Terms, including
payment terms, for the indebtedness that arose out of the Amended Credit
Agreement have been established by the Second Amended Joint Plan of
Reorganization approved by the United States Bankruptcy Court for the Middle
District of Tennessee (the Approved Plan) and are discussed in more detail in
Note 14. The terms of the Amended Credit Agreement have been superseded by the
terms of the Second Amended Joint Plan of Reorganization.

Historical Terms of the Bank Credit Facility.Prior to August 12, 2002,
Deutsche Bank Trust Company, successor to Bankers Trust Company, served as
agent for the Lenders under the Amended Credit Agreement. On August 12, 2002
the Company received written notice that Deutsche Bank Trust Company intended
to resign. Bank of Montreal was appointed by the Lenders as the new agent.

The Amended Credit Agreement was the latest in a series of credit agreements in
connection with a credit facility (the Bank Credit Facility) that dated back
to October 20, 1994. The Amended

41



---



##### Table of Contents



Credit Agreement was entered into after the Company breached several of the
financial covenants in the Fourth Amended and Restated Credit Agreement.

The Amended Credit Agreement provided a new loan to the Company from which the
proceeds were used to pay off all existing loans under the Fourth Amended and
Restated Credit Agreement. The Amended Credit Agreement also included modified
financial covenants and a revised amortization schedule. In addition, the
Amended Credit Agreement no longer contained a revolving loan component; all
existing indebtedness was now in the form of a term loan which matured on
December 31, 2002.

Substantially all of the Companys assets were pledged as security for
borrowings under the Bank Credit Facility.

The Amended Credit Agreement required principal payments of $750,000 on
September 30, 2001 and December 31, 2001; a principal payment of $11.6 million
on March 31, 2002; principal payments of $1.0 million on June 30, 2002 and
September 30, 2002; and a balloon payment of $281.5 million on December 31,
2002. The Amended Credit Agreement further provided for mandatory prepayments
of principal from the Companys excess cash flow and from the proceeds of the
Companys sales of securities, sales of assets, tax refunds or excess casualty
loss payments.

As of July 31, 2002, the Company had paid the $750,000 principal payment due on
September 30, 2001, the $750,000 principal payment due on December 31, 2001,
the $11.6 million principal payment due on March 31, 2002 as well as the $1.0
million principal payment due on June 30, 2002, the $1.0 million principal
payment due on September 30, 2002, and $6.1 million of the balloon payment due
on December 31, 2002. These early payments of 2002 principal were generated
from operational cash flows, from the sales of assets of centers, from the
sales of the Companys wholly-owned real estate and from the collection of
patient receivables associated with the asset sales. The Bankruptcy Filing
stayed all remaining payments required by the Amended Credit Agreement.

The Amended Credit Agreement further provided for the payment to the Lenders of
certain fees. These fees included a restructuring fee of $1.2 million (paid on
the effective date of the Amended Credit Agreement), and $200,000 paid on
December 31, 2001, March 31, 2002 and June 30, 2002. A restructuring fee of
$459,000 payable on September 30, 2002 is currently classified as a liability
subject to compromise in the accompanying consolidated balance sheet as of June
30, 2003. In addition, the Company had an obligation to pay the agent an
annual administrative fee of $75,000 and an annual fee of 0.50% of the average
monthly outstanding indebtedness on each anniversary of the Amended Credit
Agreement. The last such payment of annual fees was made by the Company in
June 2002.

The Amended Credit Agreement contained various financial covenants, the most
restrictive of which related to measurements of EBITDA (as defined in the
Amended Credit Agreement), leverage, interest coverage ratios, and collections
of accounts receivable. The Amended Credit Agreement also contained provisions
for periodic reporting.

The Amended Credit Agreement also contained restrictions which, among other
things, imposed certain limitations or prohibitions on the Company with respect
to the incurrence of indebtedness,
the creation of liens, the payment of dividends, the redemption or repurchase
of securities,

42



---



##### Table of Contents



investments, acquisitions, capital expenditures, sales of assets
and transactions with affiliates. The Company was not permitted to make
acquisitions or investments in joint ventures without the consent of Lenders
holding a majority of the lending commitments under the Bank Credit Facility.
In addition, proceeds of all of the Companys accounts receivable were
transferred daily into a bank account at PNC Bank, N.A. which, under the terms
of a Concentration Bank Agreement, required that all amounts in excess of $3.0
million be transferred to an account at Deutsche Bank Trust Company
(predecessor agent for the Lenders) in the Companys name. Upon occurrence of
an event of default under the Amended Credit Agreement, the Lenders had the
right to instruct PNC Bank, N.A. and Deutsche Bank Trust Company to cease
honoring any drafts under the accounts and apply all amounts in the bank
accounts against the indebtedness owed to the Lenders.

Interest was payable on the unpaid principal amount under the Amended Credit
Agreement, at the election of the Company, at either a Base Lending Rate or an
Adjusted Eurodollar Rate (each as defined in the Amended Credit Agreement),
plus an applicable margin of 2.75% and 3.50%, respectively. The Company was
also required to pay additional interest in the amount of 4.50% per annum on
that principal portion outstanding of the Amended Credit Agreement that is in
excess of four times adjusted EBITDA, as defined by the Amended Credit
Agreement. For the seven months ended with the Bankruptcy Filing, the weighted
average borrowing rate was 7.3%. Upon the occurrence and continuation of an
event of default under the Amended Credit Agreement, interest would have been
payable upon demand at a rate that is 2.00% per annum in excess of the interest
rate otherwise payable under the Amended Credit Agreement and the Company no
longer would have had the right to designate the Adjusted Eurodollar Rate plus
the applicable margin as the applicable interest rate.

Warrants.The Company was required to issue warrants to the Lenders
representing 19.999% of the common stock of the Company issued and outstanding
as of March 31, 2001, pursuant to the terms of the Second Amendment to the
Fourth Amended and Restated Credit Agreement (which amendment was entered into
on April 14, 1999). To fulfill these obligations, warrants to purchase
3,265,315 shares of common stock were issued to the Lenders on June 8, 2001.
Fifty percent of these warrants are exercisable until May 31, 2011, and the
remaining fifty percent are exercisable until September 29, 2011. The exercise
price of the warrants is $0.01 per share. The Company accounted for the fair
value of these warrants during the fourth quarter of 2000 as the issuance of
these warrants was determined to be probable. As such, the Company increased
deferred financing costs by $686,000 to recognize the estimated fair value of
the warrants as of December 31, 2000. There can be no assurance that the
Bankruptcy Court will grant approval to reject these warrants as executory
contracts. See Note 14 to the interim condensed consolidated financial
statements for additional discussion Subsequent Events.

Liquidity and Capital Resources

At June 30, 2003, the Company had current assets of $95.7 million and current
liabilities of $30.5 million, resulting in working capital of $65.2 million and
current ratio of 3.1x as compared to a working capital of $67.1 million and a
current ratio of 3.2x at December 31, 2002.

On July 1, 2003, the Companys Approved Plan became effective and the Company
successfully emerged from bankruptcy protection. The Approved Plan provides
for periodic payments of principal and interest to the Lenders and the
unsecured creditors.

43



---



##### Table of Contents



The Approved Plan provides that interest is payable monthly on the $250 million
secured debt at a rate of 6.785% per annum. The Approved Plan provides that
interest is payable semiannually (on June 30 and December 31 of each year) on
the Lenders unsecured debt and on the general unsecured debt at a rate of
8.3675% per annum.

The Approved Plan provides that principal is payable annually on the $250
million secured debt on March 31 of each year, beginning March 31, 2005, in the
amount of one third of the Companys Excess Cash Flow (as defined in the
Approved Plan) for the previous fiscal year. After the unsecured debt of the
Lenders and the general unsecured debt is paid in full, 100% of the Companys
Excess Cash Flow is paid on the $250 million secured debt on such dates. An
estimated prepayment of the Excess Cash Flow Payment is due on September 30,
2004 and on September 30 of each year thereafter, and shall equal one-half of
the amount of the anticipated Excess Cash Flow Payment for the fiscal year.
The maturity date of the $250 million secured debt is July 1, 2009. The
secured debt may be prepaid in whole or in part at any time without penalty.

The Approved Plan provides that principal is payable semi-annually in six equal
installments (on June 30 and December 31 of each year) beginning December 31,
2003 on the Lenders unsecured debt and on the general unsecured debt. In
addition to the scheduled payments referenced above, the holders of the
unsecured debt also receive a payment on March 31, 2004 in the amount of 100%
of the Companys Excess Cash Flow for fiscal year 2003 and payments on March
31, 2005 and March 31, 2006 in the amount of two thirds of the Companys Excess
Cash Flow for the previous fiscal year. The payments from the Companys Excess
Cash Flow are defined as Pro Rata Payments and described in more detail in the
Approved Plan and, if available to be paid, will reduce and be a
credit against any future required semi-annual payments. The Approved Plan is attached hereto as Exhibit 2.1.
Additionally, an estimated prepayment of the Pro Rata Payment is due on
September 30, 2003, September 30, 2004, and September 30, 2005 in an amount
equal to one-half of the anticipated Pro Rata Payment for each fiscal year.
The Company has not yet determined the amount of any estimated prepayment of
the Pro Rata Payment due on September 30, 2003. The Approved Plan also
allows the Company to make prepayments to holders of unsecured debt, either in
whole or in part, at any time without penalty. Any partial prepayments shall
reduce and be a credit against any mandatory payments that are due after the
time of the prepayment. Prior to emergence from bankruptcy protection, the
Company made adequate protection payments totaling approximately $15.8 million.
The Approved Plan provides that the adequate protection payments earn interest at a rate equal to the unsecured debt rate of 8.3675%
per annum until the date on which the adequate protection payment is applied. As of June 30, 2003 interest on the adequate protection payments totaled $552,000.
The adequate protection payments and interest will be applied to the Lenders
unsecured debt and related interest as the scheduled payments and Pro Rata
Payments become due. The maturity date of the unsecured debts is June 30,
2006.

As the reorganization value of the assets of the Debtors immediately before
confirmation date is greater than the total of all post petition liabilities
and allowed claims and the holders of the existing voting shares immediately
before the confirmation received more than 50% of the voting shares of the
Debtors, the Debtors will not apply the provisions of SOP 90-7 for fresh-start
reporting. Upon emergence from bankruptcy protection on July 1, 2003 and prior
to the
application of payments made on July 1, 2003, of the total liabilities subject
to compromise of $298,797,000 at June 30, 2003, approximately $20,806,000 and
$277,991,000 will be classified as current and non-current, respectively.

44



---



##### Table of Contents



On July 1, 2003, the Company paid, in full, unsecured claims which individually
totaled $10,000 or less, according to the provisions of the Approved Plan.
Also, on that date, the Company made a partial prepayment to the general unsecured
creditors. The total cash paid on July 1, 2003 to holders of general unsecured
debt was approximately $6.3 million.

The Approved Plan is attached hereto as Exhibit 2.1.

The Company was required to issue warrants to the Lenders representing 19.999%
of the common stock of the Company issued and outstanding as of March 31, 2001,
pursuant to the terms of the Second Amendment to the Fourth Amended and
Restated Credit Agreement (which amendment was entered into on April 14, 1999).
To fulfill these obligations, warrants to purchase 3,265,315 shares of common
stock were issued to the Lenders on June 8, 2001. Fifty percent of these
warrants are exercisable until May 31, 2011, and the remaining fifty percent
are exercisable until September 29, 2011. The exercise price of the warrants
is $0.01 per share. The Company accounted for the fair value of these warrants
during the fourth quarter of 2000 as the issuance of these warrants was
determined to be probable. As such, the Company increased deferred financing
costs by $686,000 to recognize the estimated fair value of the warrants as of
December 31, 2000. On July 11, 2003, the Company filed a motion with the
Bankruptcy Court seeking approval to reject these warrants as executory
contracts. Several warrant holders objected to this motion, and a
hearing will be scheduled in the Bankruptcy Court with respect to
these issues. If the warrants
ultimately are rejected, then the holders of the rejected warrants may have an
unsecured claim against the Company. See Note 14 to the interim condensed
consolidated financial statements Subsequent Events for additional
discussion.

The accompanying condensed consolidated interim financial statements have been
prepared on a going concern basis, which contemplates the realization of assets
and the satisfaction of liabilities in the normal course of business, and in
accordance with SOP 90-7. Accordingly, these consolidated interim financial
statements do not reflect any adjustments that might result if the Company is
unable to continue as a going concern. The Company had net income of
$4,520,000 and $8,857,000 for the three and six months ended June 30, 2003,
respectively and incurred net losses of $64,000, $66,941,000 and $61,154,000
for the three and six months ended June 30, 2002 and the year ended December
31, 2002, respectively. The Company has a shareholders deficit of $38,737,000
at June 30, 2003. The accompanying financial statements do not include any
adjustments of recorded asset carrying amounts or the amounts and
classification of liabilities that might result should the Company be unable to
continue as a going concern. All pre-petition liabilities subject to
compromise have been segregated in the condensed consolidated balance sheets
and classified as liabilities subject to compromise, at the estimated amount of
allowable claims. Liabilities not subject to compromise are separately
classified as current and non-current in the condensed consolidated balance
sheets. Revenues, expenses, realized gains and losses, and provisions for
losses and expenses resulting from the reorganization are reported separately
as Reorganization Items. Cash used for reorganization items is disclosed
separately in the condensed consolidated statements of cash flows.

Liabilities subject to compromise refer to liabilities incurred prior to the
commencement of the Chapter 11 Cases. These liabilities consist primarily of
amounts outstanding under the Bank
Credit Facility, the Government Settlement, capital leases, and also include
accounts payable, accrued interest, amounts accrued for future lease
rejections, professional fees related to the reorganization, and other accrued
expenses. Such claims remain subject to future adjustments

45



---



##### Table of Contents



based on
negotiations, actions of the Bankruptcy Court, further developments with
respect to disputed claims, and other events. Payment terms for these claims
were established in connection with the Chapter 11 Cases.

The principal categories of claims classified as liabilities subject to
compromise under reorganization proceedings are as follows:

|                                                    |                                         |   |             |             | 
|--------------------------------------------------- | --------------------------------------- | - | ----------- | ----------- | 
|Pre-petition accounts payable                       |                                         | $ | 19,713,000  |            
|State income taxes payable                          |                                         |   | 394,000     |            
|Other accruals                                      |                                         |   | 5,004,000   |            
|Accrued interest                                    |                                         |   | 1,260,000   |            
|Accrued professional fees related to reorganization |                                         |   | 2,014,000   |            
|Accrual for future lease rejection damages          |                                         |   | 1,317,000   |            
|Other long-term debt and liabilities                |                                         |   | 1,847,000   |            
|Government settlement, including interest           |                                         |   | 4,337,000   |            
|Bank credit facility                                |                                         |   | 278,705,000 |            
|Adequate protection payments                        |                                         |   | (15,794,000 | )          
|                                                    |                                         |   |             |            
|                                                    | Total liabilities subject to compromise |   | $           | 298,797,000 | 
|                                                    |                                         |   |             |            

Reorganization items represent expenses that are incurred by the Company as a
result of reorganization under Chapter 11 of the Federal Bankruptcy Code.
Reorganization items for the three and six months ended June 30, 2003 were
$2,004,000 and $2,856,000, respectively, and are comprised primarily of
professional fees.

The Companys principal cash requirements are for working capital, capital
expenditures and debt service. The Company has met and intends to continue to
meet these requirements with existing cash balances, net cash provided by
operations and other available capital expenditure financing vehicles.

Management intends to improve financial performance through stabilizing and
increasing profitable revenues, decreasing and controlling expenses and
improving accounts receivable performance. Managements cash flow projections
and related operating plans indicate that the Company can operate on its
existing cash and cash flow and make all payments provided for in its Plan.
The Company has operated in this manner since the Bankruptcy Filing. However,
as with all projections, there can be no guarantee that managements
projections will be achieved.

The Companys future liquidity will continue to be dependent upon the relative
amounts of current assets (principally cash, accounts receivable and
inventories) and current liabilities (principally accounts payable and accrued
expenses). In that regard, accounts receivable can have a significant impact
on the Companys liquidity. The Company has various types of accounts
receivable, such as receivables from patients, contracts, and former owners of
acquisitions. The majority of the Companys accounts receivable are patient
receivables. Accounts receivable are generally outstanding for longer periods
of time in the health care industry than many other
industries because of requirements to provide third-party payors with
additional information subsequent to billing and the time required by such
payors to process claims. Certain accounts receivable frequently are
outstanding for more than 90 days, particularly where the account receivable
relates to services for a

46



---



##### Table of Contents



patient receiving a new medical therapy or covered by
private insurance or Medicaid. Net patient accounts receivable were $55.9
million and $55.4 million at June 30, 2003 and December 31, 2002, respectively.
Average days sales in accounts receivable (DSO) was approximately 61 days
at June 30, 2003 and December 31, 2002. The Company calculates DSO by dividing
the previous 90 days of revenue (excluding dispositions and acquisitions), net
of bad debt expense into net patient accounts receivable and multiplying the
ratio by 90 days. The Companys level of DSO and net patient receivables is
affected by the extended time required to obtain necessary billing
documentation.

The accompanying condensed financial statements have been prepared on a going
concern basis, which contemplates the realization of assets and the
satisfaction of liabilities in the normal course of business. The Company had
net income of $4,520,000 and $8,857,000 for the three and six months ended June
30, 2003, respectively and incurred net losses of $64,000, $66,941,000 and
$61,154,000 for the three and six months ended June 30, 2002 and the year ended
December 31, 2002, respectively. The Company has a shareholders deficit of
$38,737,000 at June 30, 2003.

Net cash provided by operating activities was $18.9 million and $10.8 million
for the six months ended June 30, 2003 and 2002, respectively. This increase
of $8.1 million is primarily due to an increase in income before cumulative
effect of change in accounting principle. Income before cumulative effect of
change in accounting principle increased from $1.5 million for the six months
ended June 30, 2002 to $8.9 million for the six months ended June 30, 2003.
This increase of $7.4 million is primarily the result of increased revenue and
lower bad debt, amortization, and interest expenses. In addition, this
increase was partially offset by changes in accounts receivable; inventories;
prepaid expenses and other current assets; accounts payable, other payables and
accrued expenses; other assets and liabilities; and other noncurrent
liabilities increased cash provided by operating activities. These items
provided cash of $2.7 million for the six months ended June 30, 2003, while
these same items provided cash of $3.7 million for the same period in 2002.
Net cash provided by reorganization items totaled $0.2 million for the six
months ended June 30, 2003 and consists primarily of professional fees. Net
cash used in investing activities was $11.6 million and $9.6 million for the
six months ended June 30, 2003 and 2002, respectively. Additions to property
and equipment, net were $13.8 million for the six months ended June 30, 2003
compared to $13.0 million for the same period in 2002, and proceeds from the
sales of assets of centers contributed $1.8 million for the six months ended
June 30, 2002. Net cash used in financing activities was $8.6 million and $5.7
million for the six months ended June 30, 2003 and 2002, respectively. The
cash used in financing activities for the six months ended June 30, 2003
primarily relates to adequate protection payments to the Lenders of $7.8
million. For the six months ended June 30, 2002 cash used in financing
activities primarily relates to principal payments on debt of $6.0 million. At
June 30, 2003 the Company had cash and cash equivalents of approximately $21.5
million.

Risk Factors

This section summarizes certain risks, among others, that should be considered
by stockholders and prospective investors in the Company.

Medicare Reimbursement for Oxygen Therapy and Other Services.The Company
has been affected by previous cuts in Medicare reimbursement rates for oxygen
therapy and other

47



---



##### Table of Contents



services. Additional reimbursement reductions for oxygen
therapy services or other services and products provided by the Company could
occur. Reimbursement reductions already implemented have materially adversely
affected the Companys revenues and net income, and any such future reductions
could have a similar material adverse effect. See Managements Discussion and
Analysis of Financial Condition and Results of Operations  Medicare
Reimbursement for Oxygen Therapy Services.

Dependence on Reimbursement by Third-Party Payors.For the six months
ended June 30, 2003, the percentage of the Companys revenues derived from
Medicare, Medicaid and private pay was 52%, 9% and 39%, respectively. The
revenues and profitability of the Company may be impacted by the efforts of
payors to contain or reduce the costs of health care by lowering reimbursement
rates, narrowing the scope of covered services, increasing case management
review of services and negotiating reduced contract pricing. Reductions in
reimbursement levels under Medicare, Medicaid or private pay programs and any
changes in applicable government regulations could have a material adverse
effect on the Companys revenues and net income. Changes in the mix of the
Companys patients among Medicare, Medicaid and private pay categories and
among different types of private pay sources may also affect the Companys
revenues and profitability. There can be no assurance that the Company will
continue to maintain its current payor or revenue mix. See Managements
Discussion and Analysis of Financial Condition and Results of Operations 
Significant Accounting Policies  Revenue Recognition and Allowance for
Doubtful Accounts.

Collectibility of Accounts Receivable.The Company has substantial
accounts receivable, as well as DSO of 61 days as of June 30, 2003. No
assurances can be given that future bad debt expense will not increase above
current operating levels as a result of difficulties associated with the
Companys billing activities and meeting payor documentation requirements and
claim submission deadlines. Increased bad debt expense or delays in collecting
accounts receivable could have a material adverse effect on cash flows and
results of operations. See Managements Discussion and Analysis of Financial
Condition and Results of Operations  Significant Accounting Policies  Revenue
Recognition and Allowance for Doubtful Accounts.

Substantial Leverage.The Company maintains a significant amount of debt.
Indebtedness to the Lenders totals approximately $278.7 million as of June 30,
2003, prior to the application of the adequate protection payments made during
the bankruptcy proceedings. Under the Approved Plan, a substantial portion of
the Companys cash flow from operations will be dedicated to repaying debt.
The Companys funding of day-to-day operations going forward and of all
payments required under the Approved Plan will rely on cash flow and cash on
hand. If the Company is unable to generate sufficient cash flow to meet these
obligations, it likely would have a material adverse effect on the Company.
The substantial leverage could adversely affect the Companys ability to grow
its business or to withstand adverse economic conditions or competitive
pressures. See Note 3 to the interim condensed consolidated financial
statements Proceedings Under Chapter 11 of the Bankruptcy Code and Note 14 to
the interim condensed consolidated financial statements Subsequent Events.

Bankruptcy Appeal. On July 1, 2003, the Approved Plan became effective
and the Company successfully emerged from bankruptcy protection. The Lenders
filed an appeal of the
order confirming the Approved Plan. If an appeal is successful, it could have
a material adverse effect on the Company. See Note 3 to the interim condensed
consolidated financial statements

48



---



##### Table of Contents



Proceedings Under Chapter 11 of the
Bankruptcy Code and Note 14 to the interim condensed consolidated financial
statements Subsequent Events.

HIPAA Compliance.HIPAA has mandated an extensive set of regulations to
protect the privacy of individually identifiable health information. The
regulations consist of three sets of standards, each with a different date for
required compliance: (1) Privacy Standards have a compliance date of April 14,
2003; (2) Transactions and Code Sets Standards required compliance by October
16, 2002 except as extended by one year to October 16, 2003 for providers that
filed a compliance extension form by October 15, 2002; and (3) recently
published Security Standards that have an implementation date of April 21,
2005. The Company has filed its compliance extension form and is actively
pursuing its strategies toward compliance with the final Privacy Standards and
Transaction and Code Sets Standards. The Companys HIPAA compliance plan will
require modifications to existing information management systems and physical
security mechanisms, and may require additional personnel as well as extensive
training of existing personnel, the full cost of which has not yet been
determined. The Company cannot predict the impact that the HIPAA Transaction
and Code Set Standards, when fully implemented, will have on operations.
Further, the Company cannot predict whether all payors and clearinghouses will
be fully HIPAA Transaction compliant and able to process electronic claims by
October 16, 2003, the implementation deadline. Alternative methods of claims
submission may be required, possibly resulting in delay in payment, which could
have a material adverse effect on the Companys results of operations, cash
flow, and financial condition.

Government Regulation.The Company is subject to extensive and frequently
changing federal, state and local regulation. In addition, new laws and
regulations are adopted periodically to regulate products and services in the
health care industry. Changes in laws or regulations or new interpretations of
existing laws or regulations can have a dramatic effect on operating methods,
costs and reimbursement amounts provided by government and other third-party
payors. There can be no assurance that the Company is in compliance with all
applicable existing laws and regulations or that the Company will be able to
comply with any new laws or regulations that may be enacted in the future.
Changes in applicable laws, any failure by the Company to comply with existing
or future laws, regulations or standards, or discovery of past regulatory
noncompliance by the Company could have a material adverse effect on the
Companys results of operations, financial condition, business or prospects.
See Managements Discussion and Analysis of Financial Condition and Results of
Operations  Government Regulation.

Government Investigations and Federal False Claims Act Cases.In addition
to the regulatory initiatives mentioned above, the OIG has received funding to
expand and intensify its auditing of the health care industry in an effort to
better detect and remedy errors in Medicare and Medicaid billing. There can be
no assurances as to the final outcome of any pending False Claims Act lawsuits
against the Company or any lawsuits that may be filed in the future. Possible
outcomes include, among other things, the repayment of reimbursements
previously received by the Company related to billed claims found to be
improper, the imposition of fines or penalties, and the suspension or exclusion
of the Company from participation in the Medicare, Medicaid and other
government reimbursement programs. The outcome of any of the pending lawsuits
could have a

49



---



##### Table of Contents



material adverse effect on the Company. See Managements Discussion and
Analysis of Financial Condition and Results of Operations  Government
Regulation.

Shareholders Liquidity.Effective at the close of business on September
1, 1999, Nasdaq de-listed the Companys common stock and it is no longer listed
for trading on the Nasdaq National Market. As a result, between September 1,
1999 and September 30, 2002, trading of the Companys common stock was
conducted on the over-the-counter market (OTC) or, on application by
broker-dealers, in the NASDs Electronic Bulletin Board using the Companys
current trading symbol, AHOM. Because the Company was unable to timely file
its Form 10-Q for the quarter ended September 30, 2002, the Companys common
stock has traded only in the pink sheets since that date. On June 9, 2003,
the Companys common stock resumed trading on the OTC or, on application by
broker-dealers, in the NASDs Electronic Bulletin Board using the Companys
current trading symbol, AHOM. The liquidity of the Companys common stock and
its price have been adversely affected by the trading status of its common
stock, which may limit the Companys ability to raise additional capital and
the ability of shareholders to sell their shares.

Role of Managed Care.As managed care assumes an increasingly significant
role in markets in which the Company operates, the Companys success will, in
part, depend on retaining and obtaining profitable managed care contracts.
There can be no assurance that the Company will retain or obtain such managed
care contracts. In addition, reimbursement rates under managed care contracts
are likely to continue to experience downward pressure as a result of payors
efforts to contain or reduce the costs of health care by increasing case
management review of services and negotiating reduced contract pricing.
Therefore, even if the Company is successful in retaining and obtaining managed
care contracts, unless the Company also decreases its cost for providing
services and increases higher margin services, it will experience declining
profitability.

Health Care Initiatives.The health care industry continues to undergo
dramatic changes influenced in larger part by federal legislative initiatives.
Under the Bush administration, new federal health care initiatives may be
launched. For example, adding a prescription drug benefit to Medicare, a
patients bill of rights, providing an array of protections for managed care
patients, and changes to Medicare funding are a few of the initiatives
currently under discussion. There can be no assurance that these or other
federal legislative and regulatory initiatives will not be adopted in the
future. It is also possible that proposed federal legislation will include
language that provides incentives to further encourage Medicare recipients to
shift to Medicare at-risk managed care programs, potentially limiting patient
access to, and reimbursement for, products and services provided by the
Company. Some states are adopting health care programs and initiatives as a
replacement for Medicaid. There can be no assurance that the adoption of such
legislation or other changes in the administration or interpretation of
government health care programs or initiatives will not have a material adverse
effect on the Company.

Ability to Attract and Retain Management.The Company is highly dependent
upon its senior management, and competition for qualified management personnel
is intense. Any limit on the Companys ability to attract and retain qualified
personnel could adversely affect profitability.

50



---



##### Table of Contents



Competition.The home health care market is highly fragmented and
competition varies significantly from market to market. In the small and
mid-size markets in which the Company primarily operates, the majority of its
competition comes from local independent operators or hospital-based
facilities, whose primary competitive advantage is market familiarity. In the
larger markets, regional and national providers account for a significant
portion of competition. Some of the Companys present and potential competitors
are significantly larger than the Company and have, or may obtain, greater
financial and marketing resources than the Company. In addition, there are
relatively few barriers to entry in the local markets served by the Company,
and it encounters substantial competition from new market entrants.

Liability and Adequacy of Insurance.The provision of health care
services entails an inherent risk of liability. Certain participants in the
home health care industry may be subject to lawsuits that may involve large
claims and significant defense costs. It is expected that the Company
periodically will be subject to such suits as a result of the nature of its
business. The Company currently maintains product and professional liability
insurance intended to cover such claims in amounts which management believes
are in keeping with industry standards. There can be no assurance that the
Company will be able to obtain liability insurance coverage in the future on
acceptable terms, if at all. There can be no assurance that claims in excess
of the Companys insurance coverage will not arise. A successful claim against
the Company in excess of the Companys insurance coverage could have a material
adverse effect upon the results of operations, financial condition or prospects
of the Company. Claims against the Company, regardless of their merit or
eventual outcome, may also have a material adverse effect upon the Companys
ability to attract patients or to expand its business. In addition, the
Company is self-insured for its workers compensation insurance and employee
health insurance and is at risk for claims up to individual stop loss and
aggregate stop loss amounts.

Recent Accounting Pronouncements

In June 2001, the Financial Accounting Standards Board (FASB) issued
Statement of Financial Accounting Standards No. 141, Business Combinations
(SFAS No. 141) and SFAS No. 142. SFAS No. 141 requires that the purchase
method of accounting be used for all business combinations initiated after June
30, 2001. SFAS No. 141 also specifies criteria which intangible assets
acquired in a purchase method business combination must meet to be recognized
and reported apart from goodwill. The Company adopted SFAS No. 141 effective
July 1, 2001. See Footnote 12 Adoption of SFAS No. 142 for disclosure of the
impact of SFAS No. 142. The Company adopted SFAS No. 142 on January 1, 2002.

In June 2001, the FASB issued Statement of Financial Accounting Standards No.
143, Accounting for Asset Retirement Obligations (SFAS No. 143) effective
for fiscal years beginning after June 15, 2002. SFAS No. 143 requires that a
liability for an asset retirement obligation be recognized in the period in
which it is incurred if a reasonable estimate of fair value can be made. The
Companys January 1, 2003 adoption of SFAS No. 143 did not have a material
impact on its financial position or results of operations.

In August 2001, the FASB issued Statement of Financial Accounting Standards No.
144, Accounting for the Impairment or Disposal of Long-Lived Assets (SFAS
No. 144) effective for fiscal years beginning after December 15, 2001. SFAS
No. 144 establishes a single accounting

51



---



##### Table of Contents



model for long-lived assets to be disposed of by sale, whether previously held
and used or newly acquired, and broadens the presentation of discontinued
operations to include more disposal transactions. The Companys January 1,
2002 adoption of SFAS No. 144 did not have a material impact on its financial
position or results of operations.

In April 2002, the FASB issued Statement of Financial Accounting Standards No.
145, Rescission of FASB Statement No. 4, 44, and 64, Amendment of FASB
Statement No. 13, and Technical Corrections (SFAS No. 145). SFAS No. 145
rescinds SFAS No. 4, Reporting Gains and Losses from Extinguishment of Debt,
and an amendment of that Statement, SFAS No. 64, Extinguishment of Debt Made
to Satisfy Sinking-Fund Requirements. SFAS No. 145 also rescinds SFAS No. 44,
Accounting for Intangible Assets of Motor Carriers. SFAS No. 145 amends SFAS
No. 13, Accounting for Leases, to eliminate an inconsistency between the
required accounting for sale-leaseback transactions and the required accounting
for certain lease modifications that have economic effects that are similar to
sale-leaseback transactions. This Statement also makes several technical
corrections and clarifications to other existing authoritative pronouncements.
The provisions of this Statement related to the rescission of SFAS No. 4 are
effective for fiscal years beginning after May 15, 2002. The provisions of
this Statement related to SFAS No. 13 are effective for transactions occurring
after May 15, 2002. All other provisions of this Statement are effective for
financial statements issued on or after May 15, 2002. The Companys adoption
of the provisions of SFAS No. 145 which were effective for transactions after
May 15, 2002 has not had a material effect on its financial statements. The
Companys January 1, 2003 adoption of the remaining provisions of SFAS No. 145
did not have a material impact on its financial position or results of
operations.

In June 2002, the FASB issued Statement of Financial Accounting Standards No.
146, Accounting for Costs Associated with Exit or Disposal Activities (SFAS
No. 146) effective for exit or disposal activities that are initiated after
December 31, 2002. SFAS No. 146 addresses financial accounting and reporting
for costs associated with exit or disposal activities and nullifies Emerging
Issues Task Force Issue No. 94-3, Liability Recognition for Certain Employee
Termination Benefits and Other Costs to Exit an Activity (including Certain
Costs Incurred in a Restructuring)(Issue 94-3). The principal difference
between SFAS No. 146 and Issue 94-3 relates to the requirements for recognition
of a liability for a cost associated with an exit or disposal activity. SFAS
No. 146 requires that a liability for a cost associated with an exit or
disposal activity be recognized when the liability is incurred. Under Issue
94-3, a liability for an exit cost as defined in Issue 94-3 was recognized at
the date of an entitys commitment to an exit plan. The Companys January 1,
2003 adoption of SFAS No. 146 did not have a material impact on its financial
position or results of operations.

In December 2002, the FASB issued Statement of Financial Accounting Standards
No. 148, Accounting for Stock-Based Compensation-Transition and Disclosure-an
amendment of FASB Statement No. 123 (SFAS No. 148), which amends SFAS No.
123, Accounting for Stock-Based Compensation, to provide alternative methods
of transition for a voluntary change to the fair value based method of
accounting for stock-based employee compensation. In addition, this Statement
amends the disclosure requirements of SFAS No. 123 to require prominent
disclosures in both annual and interim financial statements about the method of
accounting for stock-based employee compensation and the effect of the method
used on reported results. The disclosure provisions of this Statement are
effective for financial statements for annual and interim periods beginning
after December 15, 2002. The Company is currently assessing the three
alternative

52



---



##### Table of Contents



methods of transition for a voluntary change to the fair value based method of
accounting for stock-based employee compensation included in this Statement.
See Note 13 to the interim condensed consolidated financial statements Stock
Based Compensation.

In November 2002, the FASB issued Interpretation No. 45, Guarantors
Accounting and Disclosure Requirements for Guarantees, Including Indirect
Guarantees of Indebtedness of Others, an Interpretation of FASB Statements No.
5, 57, and 107 and Rescission of FASB Interpretation No. 34 (FIN No. 45).
This Interpretation requires guarantors to account at fair value for and
disclose certain types of guarantees. The Interpretations disclosure
requirements are effective for the Companys year ended December 31, 2002; the
Interpretations accounting requirements are effective for guarantees issued or
modified after December 31, 2002. The Companys adoption of this
Interpretations accounting requirements did not have a material impact on its
financial position or results of operations.

In January, 2003, the FASB issued Interpretation No. 46, Consolidation of
Variable Interest Entities (FIN No. 46). This Interpretation requires
consolidation of variable interest entities (VIE) (formerly referred to as
special purpose entities) if certain conditions are met. The Interpretation
applies immediately to VIEs created after January 31, 2003, and to variable
interests obtained in VIEs after January 31, 2003. Effective with the quarter
beginning July 1, 2003, the Interpretation applies also to VIEs created or
variable interests obtained in VIEs before January 31, 2003. The Companys
adoption of the applicable provisions of this Interpretation did not have a
material impact on its financial position or results of operations. The
Company does not expect the adoption of the remaining provisions of this
Interpretation to have a material impact on its financial position or results
of operations.

53



---



##### Table of Contents



ITEM 3  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Prior to the Bankruptcy Filing, the chief market risk factor affecting the
financial condition and operating results of the Company was interest rate
risk. The Companys Bank Credit Facility provided for a floating interest
rate. The Company was not required to pay interest during its bankruptcy
proceedings. The Approved Plan provides for a fixed interest rate for both the
$250 million secured debt and the Companys unsecured debt. Interest expense
associated with other debts would not materially impact the Company as most
interest rates are fixed.

ITEM 4  CONTROLS AND PROCEDURES

Based on their evaluation of the effectiveness of the Companys disclosure
controls and procedures as of the end of the period covered by this Report, the
Chief Executive Officer and Chief Financial Officer have concluded that such
controls and procedures are adequate.

54



---



##### Table of Contents






PART II. OTHER INFORMATION

ITEM 1  LEGAL PROCEEDINGS

A description of the Chapter 11 Cases is set forth in Note 3 to the Companys
interim condensed consolidated financial statements contained in this Report
and is incorporated herein by reference. All of the civil legal proceedings
against the Company were stayed by the Bankruptcy Filing. A summary of the
Companys material legal proceedings that existed as of the Bankruptcy Filing
is set forth in Managements Discussion and Analysis of Financial Condition
and Results of Operations  Government Regulation  Legal Proceedings.

ITEM 3  DEFAULTS UPON SENIOR SECURITIES

A discussion of defaults and certain matters of non-compliance with certain
covenants contained in the Companys principal debt agreements is set forth in
Note 2 to the Companys condensed consolidated financial statements contained
in this Report and is incorporated herein by reference.

ITEM 4  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

The 2003 annual meeting of shareholders was held on June 27, 2002. At the
meeting, the reelection of the sole individual nominated as a Class 3 director
of the Companys Board of Directors, Donald R. Millard, was approved.
Continuing directors consisted of: Class 1, director Henry T. Blackstock; and
Class 2 director Joseph F. Furlong, III. No other matters were voted upon at
the annual meeting.

The following table sets forth the voting tabulation for the matter voted upon
at the meeting:

|                                                 |  |       |            |         |  |          |     |             |  |           |         |        |  |  |     |  |  |  |     | 
|------------------------------------------------ |  | ----- | ---------- | ------- |  | -------- | --- | ----------- |  | --------- | ------- | ------ |  |  | --- |  |  |  | --- | 
|                                                 |  | Votes |            | Votes   |  | Votes    |     |             |  |           |         | Broker
|                                                 |  | For   |            | Against |  | Withheld |     | Abstentions |  | Non-Votes
|                                                 |  |       |            |         |  |          |     |             |  |          
|Reelection of Class 3
director Donald R.
Millard |  |       | 12,801,206 |         |  |          | N/A |             |  |           | 192,722 |        |  |  | N/A |  |  |  | N/A | 

ITEM 6  EXHIBITS AND REPORTS ON FORM 8-K



|(A) |  | Exhibits. The exhibits filed as part of this Report are listed on the
Index to Exhibits immediately following the signature page.
|--- |  | ---------------------------------------------------------------------------------------------------------------------------------
|   
|(B) |  | Reports on Form 8-K. The Company filed the following reports on Form 8-K
during the quarterly period ended June 30, 2003:        



| | 1) |  | A current report on Form 8-K was filed on April 16, 2003 to
announce, under Item 7, a press release reporting results for the
fiscal year ended December 31, 2002, the quarters ended September
30, 2002 and December 31, 2002, and the restated fiscal year ended
December 31, 2001 and quarters ended March 31, 2002 and June 30,
2002.
| | -- |  | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

55



---



##### Table of Contents





| | 2) |  | A current report on Form 8-K was filed on May 19, 2003 to
announce, under Item 5, a press release reporting that the U. S.
Bankruptcy Court for the Middle District of Tennessee confirmed the
Companys plan of reorganization under Chapter 11 of the United
States Bankruptcy Code on May 15, 2003.                                                                                                                                                                  
| | -- |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|
| | 3) |  | A current report on Form 8-K was filed on May 30, 2003 to
announce, under Item 5, that the U.S. Bankruptcy Court for the
Middle District of Tennessee issued an order confirming the
Companys plan of reorganization on May 27, 2003 and that an order
denying the secured lenders motion to re-open the proof for
confirmation hearing on joint plan of reorganization was entered by
the U.S. Bankruptcy Court for the Middle District of Tennessee on
May 22, 2003.
|
| | 4) |  | A current report on Form 8-K was filed on June 10, 2003 to
disclose, under Item 3, information regarding the Companys
confirmed plan of reorganization.                                                                                                                                                                                                                                                                                                                

56



---



##### Table of Contents






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

|                |  |                            |  |                                                                                                             
|--------------- |  | -------------------------- |  | ------------------------------------------------------------------------------------------------------------
|                |  | AMERICAN HOMEPATIENT, INC.
|                |  |                            |  |                                                                                                             
|August 14, 2003 |  | By:                        |  | /s/ Marilyn A. OHara                                                                                       
|                |  |                            |  |                                                                                                             
|                |  |                            |  | Marilyn A. OHara
Chief Financial Officer and An Officer Duly
Authorized to Sign on Behalf of the registrant

57



---



##### Table of Contents






INDEX TO EXHIBITS

|        |  |                                                                                                                                                                                                                                                          
|------- |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|EXHIBIT |  |                                                                                                                                                                                                                                                          
|NUMBER  |  | DESCRIPTION OF EXHIBITS                                                                                                                                                                                                                                  
|        |  |                                                                                                                                                                                                                                                          
|2.1     |  | Second Amended Joint Plan Of Reorganization Proposed By The Debtors and
the Official Unsecured Creditors Committee dated January 2, 2003
(incorporated by reference to Exhibit 99.3 to the Companys Current Report
on Form 8-K filed on March 27, 2003).
|3.1     |  | Certificate of Amendment to the Certificate of Incorporation of the
Company dated October 31, 1991 (incorporated by reference to Exhibit 3.2 to
Amendment No. 2 to the Companys Registration Statement No. 33-42777 on Form
S-1).                       
|3.2     |  | Certificate of Amendment to the Certificate of Incorporation of the
Company dated October 31, 1991 (incorporated by reference to Exhibit 3.2 to
Amendment No. 2 to the Companys Registration Statement No. 33-42777 on Form
S-1).                       
|3.3     |  | Certificate of Amendment to the Certificate of Incorporation of the
Company dated May 14, 1992 (incorporated by reference to Registration
Statement on Form S-8 dated February 16, 1993).                                                                
|3.4     |  | Certificate of Ownership and Merger merging American HomePatient, Inc.
into Diversicare Inc. dated May 11, 1994 (incorporated by reference to
Exhibit 4.4 to the Companys Registration Statement No. 33-89568 on Form
S-2).                             
|3.5     |  | Certificate of Amendment to the Certificate of Incorporation of the
Company dated July 8, 1996 (incorporated by reference to Exhibit 3.5 to
the Companys Report of Form 10-Q for the quarter ended June 30, 1996).                                      
|3.6     |  | Bylaws of the Company, as amended (incorporated by reference to Exhibit
3.3 to the Companys Registration Statement No. 33-42777 on Form S-1).                                                                                                           
|31.1    |  | Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 
Chief Executive Officer.                                                                                                                                                       
|31.2    |  | Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 
Chief Financial Officer.                                                                                                                                                       
|32.1    |  | Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002  Chief Executive Officer.                                                                                                         
|32.2    |  | Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002  Chief Financial Officer.                                                                                                         

58